7Baggers

IDEXX Laboratories, Inc
(NASDAQ:IDXX) 

IDXX stock logo

IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; Livestock, Poultry and Dairy; and Other s...

Founded: 1983
Full Time Employees: 9,200
Sector: Healthcare
Industry: Diagnostics & Research

Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
    Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30 2009-06-30 2009-03-31 2008-12-31 2008-09-30 2008-06-30 2008-03-31 2007-12-31 2007-09-30 2007-06-30 2007-03-31 2006-12-31 2006-09-30 2006-06-30 2006-03-31 2005-12-31 2005-09-30 2005-06-30 2005-03-31 2004-12-31 2004-09-30 2004-06-30 2004-03-31 2003-12-31 2003-09-30 2003-06-30 2003-03-31 2002-12-31 
                                                                                                  
      revenue:
                                                                                                  
      product revenue
    666,124,000 652,439,000 656,159,000 657,561,000 573,051,000 559,870,000 567,987,000 577,272,000 543,049,000 521,825,000 521,489,000 540,680,000 505,942,000 476,874,000 481,004,000 492,518,000 478,377,000 468,458,000 471,787,000 480,715,000 454,348,000 433,695,000 422,283,000 366,058,000 364,773,000 363,448,000 360,000,000 365,638,000 334,058,000 332,319,000 324,303,000 348,621,000 317,440,000 309,028,000 291,031,000 304,091,000 271,965,000 270,700,000 266,321,000 284,887,000 249,065,000 244,870,000 246,750,000 251,210,000 232,104,000 208,839,000 233,666,000 237,515,000 219,392,000 224,749,000 206,693,000 217,322,000 205,768,000 203,704,000 196,900,000 212,221,000 204,167,000 199,433,000 191,334,000 203,502,000 188,385,000 132,467,750 173,297,000 179,813,000 176,761,000 183,522,000 171,527,000 176,066,000 155,895,000 166,698,000 167,144,000 190,488,000 168,990,000 171,284,000 155,552,000 159,886,000 145,464,000                  
      service revenue
    474,696,000 438,140,000 449,080,000 451,896,000 425,376,000 394,418,000 407,556,000 426,306,000 421,046,000 379,776,000 394,038,000 402,950,000 394,253,000 351,694,000 360,657,000 368,028,000 358,172,000 332,632,000 338,634,000 345,427,000 323,359,000 287,243,000 299,506,000 271,534,000 261,563,000 241,998,000 245,303,000 254,465,000 241,998,000 217,067,000 221,145,000 232,131,000 220,216,000 197,093,000 200,945,000 204,849,000 190,056,000 172,296,000 181,987,000 181,682,000 168,485,000 154,815,000 159,637,000 162,133,000 150,373,000 143,120,000 149,857,000 152,607,000 140,811,000 129,324,000 131,604,000 135,261,000 126,338,000 115,834,000 118,575,000 123,428,000 118,509,000 107,768,000 109,620,000 114,360,000 104,287,000 72,441,000 96,331,000 101,669,000 91,764,000 86,813,000 87,593,000 89,657,000 80,560,000 76,595,000 83,949,000 90,082,000 80,084,000 73,685,000 73,833,000 77,160,000 65,691,000                  
      total revenue
    1,140,820,000 1,090,579,000 1,105,239,000 1,109,457,000 998,427,000 954,288,000 975,543,000 1,003,578,000 964,095,000 901,601,000 915,527,000 943,630,000 900,195,000 828,568,000 841,661,000 860,546,000 836,549,000 801,090,000 810,421,000 826,142,000 777,707,000 720,938,000 721,789,000 637,592,000 626,336,000 605,446,000 605,303,000 620,103,000 576,056,000 549,386,000 545,448,000 580,752,000 537,656,000 506,121,000 491,976,000 508,940,000 462,021,000 442,996,000 448,308,000 466,569,000 417,550,000 399,685,000 406,387,000 413,343,000 382,477,000 351,959,000 383,523,000 390,122,000 360,203,000 354,073,000 338,297,000 352,583,000 332,106,000 319,538,000 315,475,000 335,649,000 322,676,000 307,201,000 300,954,000 317,862,000 292,672,000 204,908,750 269,628,000 281,482,000 268,525,000 270,335,000 259,120,000                            
      yoy
    14.26% 14.28% 13.29% 10.55% 3.56% 5.84% 6.56% 6.35% 7.10% 8.81% 8.78% 9.65% 7.61% 3.43% 3.85% 4.16% 7.57% 11.12% 12.28% 29.57% 24.17% 19.08% 19.24% 2.82% 8.73% 10.20% 10.97% 6.78% 7.14% 8.55% 10.87% 14.11% 16.37% 14.25% 9.74% 9.08% 10.65% 10.84% 10.32% 12.88% 9.17% 13.56% 5.96% 5.95% 6.18% -0.60% 13.37% 10.65% 8.46% 10.81% 7.23% 5.05% 2.92% 4.02% 4.82% 5.60% 10.25% 49.92% 11.62% 12.92% 8.99% -24.20% 4.06%                                
      qoq
    4.61% -1.33% -0.38% 11.12% 4.63% -2.18% -2.79% 4.10% 6.93% -1.52% -2.98% 4.83% 8.64% -1.56% -2.19% 2.87% 4.43% -1.15% -1.90% 6.23% 7.87% -0.12% 13.21% 1.80% 3.45% 0.02% -2.39% 7.65% 4.85% 0.72% -6.08% 8.02% 6.23% 2.88% -3.33% 10.16% 4.29% -1.18% -3.91% 11.74% 4.47% -1.65% -1.68% 8.07% 8.67% -8.23% -1.69% 8.31% 1.73% 4.66% -4.05% 6.17% 3.93% 1.29% -6.01% 4.02% 5.04% 2.08% -5.32% 8.61% 42.83% -24.00% -4.21% 4.83% -0.67% 4.33%                             
      cost of revenue:
                                                                                                  
      cost of product revenue
    194,428,000 216,977,000 206,961,000 205,146,000 175,532,000 182,395,000 176,271,000 180,642,000 176,770,000 185,815,000 178,527,000 179,999,000 173,610,000 168,563,000 158,554,000 167,323,000 162,071,000 172,973,000 166,748,000 169,832,000 147,270,000 161,513,000 146,804,000 124,024,000 125,454,000 135,814,000 125,112,000 127,893,000 117,383,000 129,079,000 120,294,000 127,270,000 118,246,000 123,244,000 109,848,000 110,330,000 103,027,000 106,360,000 103,909,000 108,910,000 97,631,000 93,450,000 92,185,000 91,203,000 83,370,000 85,264,000 84,784,000 86,956,000 78,042,000 88,171,000 76,521,000 79,842,000 74,150,000 79,490,000 72,738,000 78,470,000 75,212,000 81,802,000 76,831,000 77,457,000 73,705,000 51,943,250 67,076,000 72,063,000 68,634,000 78,929,000 71,543,000 71,304,000 59,267,000 69,449,000 65,435,000 70,738,000 64,541,000 69,566,000 60,121,000 72,319,000 58,290,000                  
      cost of service revenue
    223,653,000 215,488,000 214,924,000 209,579,000 199,516,000 201,233,000 203,234,000 203,777,000 194,255,000 189,619,000 189,018,000 190,781,000 183,614,000 175,078,000 176,481,000 179,191,000 175,725,000 171,696,000 170,752,000 167,002,000 159,655,000 149,923,000 152,379,000 134,226,000 141,292,000 138,483,000 135,241,000 134,357,000 127,076,000 119,946,000 119,511,000 121,043,000 116,311,000 110,403,000 108,126,000 105,895,000 100,803,000 96,010,000 97,669,000 97,116,000 92,382,000 88,540,000 89,928,000 89,383,000 83,563,000 84,530,000 85,403,000 84,648,000 80,064,000 77,237,000 75,993,000 75,043,000 73,982,000 70,998,000 72,102,000 72,490,000 72,690,000 66,518,000 65,456,000 66,372,000 64,042,000 44,502,500 60,345,000 60,135,000 57,530,000 58,475,000 57,100,000 55,979,000 52,755,000 53,323,000 57,509,000 58,572,000 54,697,000 53,159,000 50,786,000 50,506,000 44,286,000                  
      total cost of revenue
    418,081,000 432,465,000 421,885,000 414,725,000 375,048,000 383,628,000 379,505,000 384,419,000 371,025,000 375,434,000 367,545,000 370,780,000 357,224,000 343,641,000 335,035,000 346,514,000 337,796,000 344,669,000 337,500,000 336,834,000 306,925,000 311,436,000 299,183,000 258,250,000 266,746,000 274,297,000 260,353,000 262,250,000 244,459,000 249,025,000 239,805,000 248,313,000 234,557,000 233,647,000 217,974,000 216,225,000 203,830,000 202,370,000 201,578,000 206,026,000 190,013,000 181,990,000 182,113,000 180,586,000 166,933,000 169,794,000 170,187,000 171,604,000 158,106,000 165,408,000 152,514,000 154,885,000 148,132,000 150,488,000 144,840,000 150,960,000 147,902,000 148,320,000 142,287,000 143,829,000 137,747,000 96,445,750 127,421,000 132,198,000 126,164,000 137,404,000 128,643,000                            
      gross profit
    722,739,000 658,114,000 683,354,000 694,732,000 623,379,000 570,660,000 596,038,000 619,159,000 593,070,000 526,167,000 547,982,000 572,850,000 542,971,000 484,927,000 506,626,000 514,032,000 498,753,000 456,421,000 472,921,000 489,308,000 470,782,000 409,502,000 422,606,000 379,342,000 359,590,000 331,149,000 344,950,000 357,853,000 331,597,000 300,361,000 305,643,000 332,439,000 303,099,000 272,474,000 274,002,000 292,715,000 258,191,000 240,626,000 246,730,000 260,543,000 227,537,000 217,695,000 224,274,000 232,757,000 215,544,000 182,165,000 213,336,000 218,518,000 202,097,000 188,665,000 185,783,000 197,698,000 183,974,000 169,050,000 170,635,000 184,689,000 174,774,000 158,881,000 158,667,000 174,033,000 154,925,000 -433,273,377 142,207,000 149,284,000 142,361,000 132,931,000 130,477,000 138,440,000 124,433,000 120,521,000 128,149,000 151,260,000 129,836,000 122,244,000 118,478,000 114,221,000 108,579,000                  
      yoy
    15.94% 15.33% 14.65% 12.21% 5.11% 8.46% 8.77% 8.08% 9.23% 8.50% 8.16% 11.44% 8.87% 6.25% 7.13% 5.05% 5.94% 11.46% 11.91% 28.99% 30.92% 23.66% 22.51% 6.00% 8.44% 10.25% 12.86% 7.64% 9.40% 10.23% 11.55% 13.57% 17.39% 13.24% 11.05% 12.35% 13.47% 10.53% 10.01% 11.94% 5.56% 19.50% 5.13% 6.52% 6.65% -3.45% 14.83% 10.53% 9.85% 11.60% 8.88% 7.04% 5.26% 6.40% 7.54% 6.12% 12.81% -136.67% 11.57% 16.58% 8.83% -425.94% 8.99% 7.83% 14.41% 10.30% 1.82% -8.48% -4.16% -1.41% 8.16% 32.43% 19.58%                      
      qoq
    9.82% -3.69% -1.64% 11.45% 9.24% -4.26% -3.73% 4.40% 12.72% -3.98% -4.34% 5.50% 11.97% -4.28% -1.44% 3.06% 9.27% -3.49% -3.35% 3.94% 14.96% -3.10% 11.41% 5.49% 8.59% -4.00% -3.61% 7.92% 10.40% -1.73% -8.06% 9.68% 11.24% -0.56% -6.39% 13.37% 7.30% -2.47% -5.30% 14.51% 4.52% -2.93% -3.64% 7.99% 18.32% -14.61% -2.37% 8.13% 7.12% 1.55% -6.03% 7.46% 8.83% -0.93% -7.61% 5.67% 10.00% 0.13% -8.83% 12.33% -135.76% -404.68% -4.74% 4.86% 7.09% 1.88% -5.75% 11.26% 3.25% -5.95% -15.28% 16.50% 6.21% 3.18% 3.73% 5.20%                   
      gross margin %
    63.35% 60.35% 61.83% 62.62% 62.44% 59.80% 61.10% 61.70% 61.52% 58.36% 59.85% 60.71% 60.32% 58.53% 60.19% 59.73% 59.62% 56.97% 58.35% 59.23% 60.53% 56.80% 58.55% 59.50% 57.41% 54.70% 56.99% 57.71% 57.56% 54.67% 56.04% 57.24% 56.37% 53.84% 55.69% 57.51% 55.88% 54.32% 55.04% 55.84% 54.49% 54.47% 55.19% 56.31% 56.35% 51.76% 55.63% 56.01% 56.11% 53.28% 54.92% 56.07% 55.40% 52.90% 54.09% 55.02% 54.16% 51.72% 52.72% 54.75% 52.93% -211.45% 52.74% 53.04% 53.02% 49.17% 50.35% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN%  
      expenses:
                                                                                                  
      sales and marketing
    175,250,000 167,060,000 159,157,000 161,107,000 156,223,000 150,108,000 146,281,000 142,665,000 149,453,000 142,032,000 135,698,000 140,532,000 147,804,000 131,935,000 130,021,000 130,257,000 132,292,000 128,458,000 124,434,000 119,032,000 114,811,000 115,909,000 108,202,000 94,181,000 116,143,000 105,694,000 104,551,000 101,364,000 106,584,000 95,904,000 95,146,000 96,255,000 100,101,000 90,539,000 88,818,000 87,693,000 87,244,000 80,605,000 79,972,000 76,652,000 79,829,000 76,495,000 73,107,000 75,217,000 75,136,000 77,238,000 70,602,000 68,020,000 67,848,000 63,851,000 60,079,000 57,896,000 59,397,000 52,724,000 52,067,000 54,539,000 57,632,000 52,209,000 50,682,000 50,974,000 50,985,000 -132,889,374 44,486,000 44,167,000 44,416,000 43,383,000 41,504,000 41,876,000 40,985,000 40,214,000 41,527,000 44,214,000 44,001,000 41,796,000 37,757,000 36,747,000 35,582,000                  
      general and administrative
    119,115,000 108,616,000 105,936,000 98,681,000 91,561,000 101,137,000 91,887,000 157,243,000 92,024,000 87,021,000 89,034,000 89,669,000 70,101,000 83,047,000 83,764,000 81,488,000 77,949,000 83,466,000 82,098,000 73,326,000 70,770,000 69,721,000 105,031,000 60,268,000 65,812,000 74,664,000 66,337,000 59,955,000 60,361,000 58,972,000 63,955,000 61,080,000 60,931,000 55,318,000 57,186,000 55,460,000 52,914,000 50,778,000 52,627,000 54,317,000 49,295,000 48,793,000 46,198,000 44,920,000 42,599,000 45,257,000 45,698,000 41,846,000 41,089,000 40,990,000 38,651,000 38,858,000 41,631,000 31,849,000 35,307,000 34,275,000 36,178,000 31,170,000 32,483,000 33,140,000 32,596,000 -96,461,481 30,704,000 33,076,000 32,808,000 29,393,000 28,185,000 30,794,000 29,068,000 27,274,000 29,705,000 29,881,000 29,821,000 26,937,000 27,343,000 27,690,000 26,149,000                  
      research and development
    65,788,000 66,833,000 63,415,000 61,898,000 59,061,000 57,729,000 53,978,000 55,450,000 52,635,000 51,812,000 47,967,000 46,505,000 44,667,000 43,418,000 48,013,000 123,221,000 40,168,000 45,306,000 40,427,000 37,697,000 37,579,000 38,777,000 37,517,000 31,645,000 33,310,000 35,160,000 34,260,000 32,259,000 31,514,000 30,138,000 29,192,000 29,510,000 29,023,000 28,809,000 27,585,000 26,998,000 25,790,000 25,418,000 25,672,000 25,412,000 24,620,000 25,496,000 24,862,000 24,317,000 25,006,000 24,869,000 24,847,000 25,433,000 23,114,000 22,496,000 21,568,000 22,181,000 21,758,000 21,050,000 20,349,000 20,058,000 20,557,000 20,203,000 19,406,000 18,621,000 17,812,000 -51,049,403 17,203,000 17,206,000 16,709,000 16,008,000 16,583,000 16,594,000 15,939,000 17,184,000 17,920,000 18,274,000 17,295,000 16,769,000 17,281,000 17,317,000 15,971,000                  
      total operating expenses
    360,153,000                                                                                              
      income from operations
    362,586,000 315,605,000 354,846,000 373,046,000 316,534,000 261,686,000 303,892,000 263,801,000 298,958,000 245,302,000 275,283,000 296,144,000 280,399,000 226,527,000 244,828,000 179,066,000 248,344,000 199,191,000 225,962,000 259,253,000 247,622,000 185,095,000 171,856,000 193,248,000 144,325,000 115,631,000 139,802,000 164,275,000 133,138,000 115,347,000 117,350,000 145,594,000 113,044,000 97,808,000 100,413,000 122,564,000 92,243,000 83,825,000 88,459,000 104,162,000 73,793,000 66,911,000 71,895,000 88,303,000 72,803,000 34,801,000 72,189,000 83,219,000 70,046,000 61,328,000 65,485,000 78,763,000 61,188,000 63,427,000 62,912,000 75,817,000 60,407,000 55,299,000 56,096,000 71,298,000 53,532,000 -152,873,119 49,814,000 54,835,000 48,428,000 44,147,000 44,205,000 49,176,000 38,441,000 35,849,000 38,997,000 58,891,000 38,719,000 36,742,000 36,097,000 32,467,000 30,877,000                  
      yoy
    14.55% 20.60% 16.77% 41.41% 5.88% 6.68% 10.39% -10.92% 6.62% 8.29% 12.44% 65.38% 12.91% 13.72% 8.35% -30.93% 0.29% 7.62% 31.48% 34.16% 71.57% 60.07% 22.93% 17.64% 8.40% 0.25% 19.13% 12.83% 17.78% 17.93% 16.87% 18.79% 22.55% 16.68% 13.51% 17.67% 25.00% 25.28% 23.04% 17.96% 1.36% 92.27% -0.41% 6.11% 3.94% -43.25% 10.24% 5.66% 14.48% -3.31% 4.09% 3.89% 1.29% 14.70% 12.15% 6.34% 12.84% -136.17% 12.61% 30.02% 10.54% -446.28% 12.69% 11.51% 25.98% 23.15% 13.35% -16.50% -0.72% -2.43% 8.03% 81.39% 25.40%                      
      qoq
    14.89% -11.06% -4.88% 17.85% 20.96% -13.89% 15.20% -11.76% 21.87% -10.89% -7.04% 5.62% 23.78% -7.48% 36.73% -27.90% 24.68% -11.85% -12.84% 4.70% 33.78% 7.70% -11.07% 33.90% 24.82% -17.29% -14.90% 23.39% 15.42% -1.71% -19.40% 28.79% 15.58% -2.59% -18.07% 32.87% 10.04% -5.24% -15.08% 41.15% 10.29% -6.93% -18.58% 21.29% 109.20% -51.79% -13.25% 18.81% 14.22% -6.35% -16.86% 28.72% -3.53% 0.82% -17.02% 25.51% 9.24% -1.42% -21.32% 33.19% -135.02% -406.89% -9.16% 13.23% 9.70% -0.13% -10.11% 27.93% 7.23% -8.07% -33.78% 52.10% 5.38% 1.79% 11.18% 5.15%                   
      operating margin %
    31.78% 28.94% 32.11% 33.62% 31.70% 27.42% 31.15% 26.29% 31.01% 27.21% 30.07% 31.38% 31.15% 27.34% 29.09% 20.81% 29.69% 24.86% 27.88% 31.38% 31.84% 25.67% 23.81% 30.31% 23.04% 19.10% 23.10% 26.49% 23.11% 21.00% 21.51% 25.07% 21.03% 19.33% 20.41% 24.08% 19.97% 18.92% 19.73% 22.33% 17.67% 16.74% 17.69% 21.36% 19.03% 9.89% 18.82% 21.33% 19.45% 17.32% 19.36% 22.34% 18.42% 19.85% 19.94% 22.59% 18.72% 18.00% 18.64% 22.43% 18.29% -74.61% 18.48% 19.48% 18.03% 16.33% 17.06% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN%  
      interest expense
    -7,741,000 -9,210,000 -10,655,000 -11,321,000 -7,666,000 -7,498,000 -7,697,000 -8,099,000 -7,911,000 -9,265,000 -8,647,000 -10,542,000 -13,127,000 -13,547,000 -10,998,000 -8,317,000 -6,996,000 -7,477,000 -7,134,000 -7,613,000 -7,584,000 -7,828,000 -8,110,000 -9,495,000 -7,692,000 -7,393,000 -7,090,000 -8,186,000 -8,386,000 -8,560,000 -8,453,000 -8,457,000 -9,274,000 -9,717,000 -9,764,000 -9,155,000 -8,589,000 -7,755,000 -7,786,000 -8,204,000 -8,304,000 -7,926,000 -7,750,000 -7,259,000 -6,304,000 -5,396,000 -4,294,000 -2,965,000 -2,774,000 -1,909,000 -1,463,000 -1,179,000 -835,000 -856,000 -873,000 -926,000 -1,193,000   -782,000      -381,000 -436,000 -459,000 -640,000 -1,103,000 -1,242,000 -1,213,000 -1,031,000 -889,000 -1,202,000 -1,454,000 -634,000                  
      interest income
    597,000 587,000 580,000 627,000 1,216,000 2,199,000 2,714,000 3,354,000 4,432,000 3,631,000 1,255,000 327,000 416,000 235,000 353,000 334,000 143,000 169,000 122,000 91,000 52,000 169,000 208,000 69,000 140,000 268,000 86,000 33,000 40,000 258,000 142,000 172,000 579,000 1,595,000 1,400,000 1,176,000 1,083,000 1,057,000 851,000 928,000 820,000 800,000 684,000 559,000 425,000 457,000 313,000 488,000 471,000 540,000 456,000 444,000 444,000 513,000 473,000 480,000 436,000 506,000 450,000 419,000 369,000 -328,752 136,000 138,000 53,000 138,000 48,000 56,000 244,000 522,000 682,000 570,000 546,000 870,000 687,000 620,000 662,000                  
      income before provision for income taxes
    355,442,000 306,982,000 344,771,000 362,352,000 310,084,000 256,387,000 298,909,000 259,056,000 295,479,000 239,668,000 267,891,000 285,929,000 267,688,000 213,215,000 234,183,000 171,083,000 241,491,000 191,883,000 218,950,000 251,731,000 240,090,000 177,436,000 163,954,000 183,822,000 136,773,000 108,506,000 132,798,000 156,122,000 124,792,000 107,045,000 109,039,000 137,309,000 104,349,000 89,686,000 92,049,000 114,585,000 84,737,000 77,127,000 81,524,000 96,886,000 66,309,000 59,785,000 64,829,000 81,603,000 66,924,000 29,862,000 68,208,000 80,742,000 67,743,000 59,959,000 64,478,000 78,028,000 60,797,000 63,084,000 62,512,000 75,371,000 59,650,000 54,696,000 55,618,000 70,935,000 53,173,000 -151,460,871 49,263,000 54,284,000 48,116,000 32,658,750 43,817,000 48,773,000 38,045,000 33,729,750 38,437,000 58,248,000 38,234,000                      
      provision for income taxes
    76,996,000 58,794,000 70,161,000 68,363,000 67,407,000 40,238,000 66,068,000 55,758,000 59,900,000 45,147,000 55,660,000 61,693,000 53,634,000 41,008,000 53,245,000 39,104,000 47,526,000 29,112,000 43,772,000 49,125,000 35,801,000 2,478,000 17,633,000 34,826,000 24,917,000 17,962,000 23,960,000 30,421,000 22,083,000 21,368,000 15,825,000 28,629,000 14,873,000 51,396,000 21,535,000 29,178,000 15,679,000 24,756,000 25,072,000 29,680,000 20,284,000 15,395,000 20,600,000 24,665,000 20,346,000 3,911,000 16,045,000 23,498,000 21,150,000 16,722,000 18,786,000 24,029,000 15,930,000 19,724,000 19,639,000 24,051,000 18,916,000 16,698,000 17,122,000 22,281,000 16,567,000 -46,662,191 14,548,000 17,087,000 15,088,000 12,943,000 12,281,000 15,106,000 11,974,000 11,713,000 12,738,000 18,884,000 10,683,000 11,195,000 9,787,000 9,969,000 9,878,000                  
      net income
    278,446,000 248,188,000 274,610,000 293,989,000 242,677,000 216,149,000 232,841,000 203,298,000 235,579,000     172,207,000 180,938,000 131,979,000 193,965,000 162,771,000 175,178,000 202,606,000 204,289,000 174,958,000 146,321,000 148,996,000 111,856,000 90,544,000 108,838,000 125,701,000 102,709,000 85,677,000 93,214,000 108,680,000 89,476,000 38,290,000 70,514,000 85,407,000 69,058,000 52,371,000 56,452,000 67,206,000 46,025,000 44,390,000 44,229,000 56,938,000 46,578,000 25,951,000 52,163,000 57,244,000 46,593,000 43,237,000 45,692,000 53,999,000 44,867,000 43,360,000 42,873,000 51,320,000 40,734,000 37,998,000 38,496,000 48,654,000 36,606,000 -104,798,680 34,715,000 37,197,000 33,028,000 30,961,000 31,536,000 33,667,000 26,071,000 23,555,000 25,699,000 39,364,000 27,551,000 25,528,000 25,795,000 21,664,000 21,027,000                  
      yoy
    14.74% 14.82% 17.94% 44.61% 3.01%         5.80% 3.29% -34.86% -5.05% -6.97% 19.72% 35.98% 82.64% 93.23% 34.44% 18.53% 8.91% 5.68% 16.76% 15.66% 14.79% 123.76% 32.19% 27.25% 29.57% -26.89% 24.91% 27.08% 50.04% 17.98% 27.64% 18.03% -1.19% 71.05% -15.21% -0.53% -0.03% -39.98% 14.16% 6.01% 3.85% -0.28% 6.58% 5.22% 10.15% 14.11% 11.37% 5.48% 11.28% -136.26% 10.89% 30.80% 10.83% -438.49% 10.08% 10.49% 26.68% 31.44% 22.71% -14.47% -5.37% -7.73% -0.37% 81.70% 31.03%                      
      qoq
    12.19% -9.62% -6.59% 21.14% 12.27% -7.17% 14.53% -13.70%      -4.83% 37.10% -31.96% 19.16% -7.08% -13.54% -0.82% 16.76% 19.57% -1.80% 33.20% 23.54% -16.81% -13.42% 22.39% 19.88% -8.09% -14.23% 21.46% 133.68% -45.70% -17.44% 23.67% 31.86% -7.23% -16.00% 46.02% 3.68% 0.36% -22.32% 22.24% 79.48% -50.25% -8.88% 22.86% 7.76% -5.37% -15.38% 20.35% 3.48% 1.14% -16.46% 25.99% 7.20% -1.29% -20.88% 32.91% -134.93% -401.88% -6.67% 12.62% 6.68% -1.82% -6.33% 29.14% 10.68% -8.34% -34.71% 42.88% 7.92% -1.04% 19.07% 3.03%                   
      net income margin %
    24.41% 22.76% 24.85% 26.50% 24.31% 22.65% 23.87% 20.26% 24.44% 0% 0% 0% 0% 20.78% 21.50% 15.34% 23.19% 20.32% 21.62% 24.52% 26.27% 24.27% 20.27% 23.37% 17.86% 14.95% 17.98% 20.27% 17.83% 15.60% 17.09% 18.71% 16.64% 7.57% 14.33% 16.78% 14.95% 11.82% 12.59% 14.40% 11.02% 11.11% 10.88% 13.78% 12.18% 7.37% 13.60% 14.67% 12.94% 12.21% 13.51% 15.32% 13.51% 13.57% 13.59% 15.29% 12.62% 12.37% 12.79% 15.31% 12.51% -51.14% 12.88% 13.21% 12.30% 11.45% 12.17% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN%  
      earnings per share:
                                                                                                  
      basic
    3.5 3.11 3.43 3.66 2.98 2.65 2.83 2.46 2.84 2.34 2.55 2.7 2.58 2.08 2.17 1.57 2.3 1.92 2.06 2.37 2.39 2.05 1.71 1.75 1.31 1.06 1.26 1.46 1.19 0.99 1.07 1.25 1.02 0.44 0.81 0.97 0.78 0.58 0.63 0.75 0.51 0.48 0.48 0.61 0.99 0.56 1.05 1.12 0.9 0.83 0.87 1.01 0.82 0.79 0.78 0.93 0.74 0.68 0.68 0.85 0.64 0.63 0.6 0.64 0.57 0.53 0.54 0.57 0.44 0.4 0.43 0.66 0.45 -0.69 0.84 0.7 0.68                  
      diluted
    3.47 3.09 3.4 3.63 2.96 2.62 2.8 2.44 2.81 2.31 2.53 2.67 2.55 2.06 2.15 1.56 2.27 1.89 2.03 2.34 2.35 2.01 1.69 1.72 1.29 1.04 1.24 1.43 1.17 0.97 1.05 1.23 1.01 0.43 0.79 0.95 0.77 0.57 0.62 0.74 0.51 0.48 0.48 0.6 0.98 0.55 1.03 1.1 0.89 0.82 0.86 0.99 0.81 0.77 0.76 0.91 0.72 0.67 0.66 0.83 0.62 0.61 0.59 0.62 0.55 0.51 0.52 0.55 0.43 0.39 0.42 0.63 0.43 -0.66 0.81 0.67 0.65                  
      weighted-average shares outstanding:
                                                                                                  
      basic
    79,648 80,427 80,096 80,413 81,319 82,467 82,304 82,630 83,096 83,066 83,097 83,086 82,992 83,623 83,247 83,922 84,410 85,200 85,123 85,325 85,530 85,342 85,314 85,134 85,427 86,115 86,198 86,215 86,204 86,864 86,756 87,004 87,331 87,769 87,537 88,004 88,117 89,732 89,894 89,824 89,924 92,601 91,944 93,384 47,140 50,047 49,745 51,125 51,617 53,159 52,450 53,670 54,588 54,985  55,079 55,208 56,790 56,699 57,276 57,457 57,713    58,809 58,656 58,911 59,172 59,953 59,473 60,029 60,865 61,560 30,547 30,849 31,137             34,271     
      diluted
    80,162 81,025 80,675 80,994 81,922 83,246 83,056 83,393 83,957 83,978 83,993 83,983 83,959 84,600 84,113 84,858 85,564 86,572 86,511 86,654 86,917 86,722 86,690 86,402 86,705 87,542 87,667 87,615 87,549 88,470 88,453 88,596 88,944 89,567 89,256 89,878 89,994 90,884 91,138 90,817 90,838 93,649 92,897 94,306 47,761 50,751 50,400 51,795 52,338 53,985 53,242 54,386 55,490 56,155  56,211 56,439 58,214 58,007 58,727 59,090 59,559    60,682 60,668 60,697 60,606 62,249 61,865 62,440 63,558 64,455 31,991 32,201 32,542             35,931     
      the accompanying notes are an integral part of these condensed consolidated financial statements.
                                                                                                  
      total operating expense
     239,259,750 328,508,000 321,686,000 306,845,000                                                                                          
      net income attributable to idexx laboratories, inc. stockholders
             194,521,000 212,231,000 224,236,000 214,054,000 172,207,000 180,938,000 131,979,000 193,965,000 162,771,000 175,235,000 202,582,000 204,257,000 174,790,000 146,219,000 148,940,000 111,827,000 90,496,000 108,837,000 125,706,000 102,681,000 85,638,000 93,251,000 108,691,000 89,451,000 38,257,000 70,511,000 85,357,000 69,019,000 52,369,000 56,455,000 67,202,000 46,019,000 44,349,000 44,223,000 56,912,000 46,594,000 25,961,000 52,142,000 57,218,000 46,585,000 43,258,000 45,688,000 53,995,000 44,860,000 43,354,000 42,853,000 51,317,000 40,743,000 38,010,000 38,507,000 48,657,000 36,612,000 26,228,250 34,694,000 37,193,000 33,026,000                              
      less: net loss attributable to noncontrolling interest
                                                            -9,000                                      
      less: net income attributable to noncontrolling interest
                      -57,000 24,000 32,000 168,000 102,000 56,000 29,000 48,000 1,000 -5,000 28,000 39,000 -37,000 -11,000 25,000 33,000 3,000 50,000 39,000 2,000  4,000 6,000 41,000 6,000 26,000 -16,000 -10,000 21,000 26,000 8,000 3,750 4,000 4,000 7,000 6,000 20,000 3,000    -3,000  -26,964 21,000 4,000 2,000                              
      impairment charge
                                              8,212,000                                                    
      weighted average shares outstanding:
                                                                                                  
      basic
                                                                  57,620 57,747 58,033                              
      diluted
                                                                  59,276 59,646 60,029                              
      revenue: - sum
                                                                       265,723,000 236,455,000 243,293,000 251,093,000 280,570,000 249,074,000                      
      cost of revenue: - sum
                                                                       127,283,000 112,022,000 122,772,000 122,944,000 129,310,000 119,238,000                      
      income before provision for income taxes and partner’s interest
                                                                             24,530,000 35,582,000 31,633,000 30,905,000                  
      partner’s interest in loss of subsidiary
                                                                                                  
    Balance Sheets:
    Quarterly
    Annual
      Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30 2009-06-30 2009-03-31 2008-12-31 2008-09-30 2008-06-30 2008-03-31 2007-12-31 2007-09-30 2007-06-30 2007-03-31 2003-12-31 
                                                                                 
        assets
                                                                                 
        current assets:
                                                                                 
        cash and cash equivalents
      200,528,000 180,070,000 208,166,000 164,594,000 163,970,000 288,266,000 308,636,000 401,590,000 397,433,000 453,932,000 331,696,000 132,838,000 111,367,000 112,546,000 99,176,000 114,362,000 204,618,000 144,454,000 145,203,000 232,134,000 351,163,000 383,928,000 175,587,000 105,293,000 81,395,000 90,326,000 103,996,000 110,845,000 116,616,000 123,794,000 146,877,000 174,559,000 159,229,000 187,675,000 169,019,000 165,975,000 160,408,000 154,901,000 150,072,000 141,139,000 132,953,000 128,994,000 141,150,000 163,152,000 182,160,000 322,536,000 292,735,000 305,048,000 286,203,000 279,058,000 264,811,000 251,013,000 228,364,000 223,986,000 221,441,000 181,499,000 159,398,000 153,459,000 156,915,000 133,512,000 117,975,000 106,354,000 106,728,000 106,728,000 103,744,000 86,295,000 78,868,000 84,586,000 75,265,000 60,220,000 60,360,000 58,507,000 49,588,000 53,937,000 186,717,000 
        accounts receivable
      603,544,000 552,378,000 566,881,000 560,563,000 527,464,000 473,575,000 511,250,000 533,606,000 507,208,000 457,445,000 452,699,000 461,858,000 446,025,000 400,619,000 388,072,000 412,898,000 402,235,000 368,348,000 376,760,000 382,308,000 381,792,000 331,429,000 337,593,000 320,320,000 299,983,000 269,312,000 268,319,000 286,154,000 281,159,000 248,855,000 264,563,000 265,012,000 259,865,000 234,597,000 228,159,000 240,262,000 225,353,000 204,494,000 204,701,000 212,229,000 212,072,000 188,318,000 190,904,000 199,444,000 196,231,000 152,380,000 160,467,000 168,641,000 179,919,000 158,038,000 151,568,000 159,119,000 158,988,000 138,324,000 141,374,000 134,923,000 149,314,000 137,551,000 120,080,000 120,454,000 127,138,000 130,519,000 115,107,000 115,141,000            
        inventories
      382,400,000 377,756,000 391,564,000 392,584,000 395,987,000 381,877,000 389,804,000 379,958,000 390,599,000 380,282,000 393,974,000 395,141,000 391,011,000 367,823,000 354,975,000 332,565,000 301,638,000 269,030,000 258,484,000 241,392,000 225,559,000 209,873,000 217,597,000 229,377,000 211,644,000 195,019,000 204,893,000 196,876,000 189,468,000 173,303,000 179,684,000 176,487,000 179,039,000 164,318,000 176,749,000 169,693,000 172,183,000 158,034,000 168,468,000 175,688,000 183,759,000 188,833,000 192,405,000 184,500,000 173,370,000 160,342,000 156,007,000 145,400,000 141,134,000 133,427,000 145,987,000 140,938,000 148,242,000 140,946,000 147,474,000 137,143,000 133,934,000 127,054,000 127,885,000 131,555,000 122,032,000 122,384,000 110,425,000 124,488,000 122,924,000 123,575,000 115,926,000 112,907,000 106,182,000 99,878,000 98,804,000 96,273,000 91,551,000 106,373,000 75,333,000 
        other current assets
      267,603,000 303,623,000 310,444,000 244,616,000 230,192,000 256,179,000 224,054,000 213,458,000 206,733,000 203,595,000 205,861,000 189,188,000 201,043,000 220,489,000 216,636,000 183,000,000 181,281,000 173,823,000 157,590,000 145,392,000 139,284,000 137,508,000 137,902,000 124,622,000 128,329,000 124,982,000 126,174,000 118,423,000 110,403,000 108,220,000 113,073,000 123,774,000 103,574,000 101,140,000 83,710,000 85,805,000 80,711,000 91,206,000 63,457,000 62,991,000 62,605,000 62,069,000 63,771,000 67,559,000 81,642,000 86,451,000 60,154,000 48,829,000 43,905,000 48,957,000 35,553,000 37,460,000 33,082,000 38,567,000 35,055,000 29,934,000 24,034,000 21,387,000 29,508,000 19,488,000 19,974,000 16,240,000 18,890,000 15,993,000 16,177,000 21,745,000 28,121,000 19,624,000 13,019,000 12,130,000 14,509,000 11,259,000 11,793,000 10,530,000 6,800,000 
        total current assets
      1,454,075,000 1,413,827,000 1,477,055,000 1,362,357,000 1,317,613,000 1,399,897,000 1,433,744,000 1,528,612,000 1,501,973,000 1,495,254,000 1,384,230,000 1,179,025,000 1,149,446,000 1,101,477,000 1,058,859,000 1,042,825,000 1,089,772,000 955,655,000 938,037,000 1,001,226,000 1,097,798,000 1,062,738,000 868,679,000 779,612,000 721,351,000 679,639,000 703,382,000 712,298,000 697,646,000 654,172,000 704,197,000 739,832,000 701,707,000 971,985,000 942,722,000 918,658,000 878,588,000 845,584,000 828,100,000 821,110,000 809,006,000 821,634,000 833,396,000 833,034,000 808,909,000 759,398,000 702,621,000 701,707,000 683,166,000 652,706,000 625,223,000 614,902,000 594,395,000 569,537,000 570,774,000 510,752,000 493,571,000 465,441,000 460,591,000 429,911,000 410,552,000 398,369,000 376,338,000 385,727,000 384,337,000 367,783,000 355,890,000 353,377,000 339,064,000 322,366,000 305,663,000 293,749,000 282,468,000 296,756,000  
        long-term assets:
                                                                                 
        property and equipment
      740,382,000 747,380,000 739,437,000 739,677,000 717,624,000 713,123,000 717,745,000 708,178,000 708,725,000 702,177,000 687,101,000 683,270,000 665,439,000 649,474,000 612,405,000 594,224,000 593,457,000 587,667,000 573,385,000 550,255,000 543,963,000 555,167,000 547,624,000 550,895,000 546,158,000 533,845,000 496,584,000 469,982,000 449,103,000 437,270,000 409,980,000 394,021,000 384,246,000 379,096,000 367,513,000 364,779,000 361,233,000 357,422,000 349,664,000 347,161,000 343,010,000 333,026,000 320,337,000 326,041,000 309,827,000 303,587,000 291,701,000 286,712,000 282,226,000 281,214,000 274,158,000 266,494,000 253,742,000 245,177,000 231,639,000 213,868,000 210,163,000 202,748,000 201,725,000 200,610,000 196,714,000 197,063,000 199,946,000 196,542,000 189,660,000 186,708,000 189,646,000 178,655,000 166,604,000 151,094,000 141,852,000 126,865,000 117,806,000 108,796,000  
        operating lease right-of-use assets
      121,395,000 123,228,000 128,207,000 129,778,000 115,999,000 116,129,000 121,053,000 119,526,000 119,886,000 115,499,000 117,782,000 114,148,000 115,060,000 118,618,000 110,103,000 115,461,000 107,736,000 105,101,000 106,962,000 104,723,000 93,565,000 91,171,000 84,735,000 82,407,000 78,612,000 80,607,000 78,977,000 81,555,000 80,594,000                                               
        goodwill
      412,104,000 414,004,000 413,651,000 414,488,000 407,486,000 405,100,000 412,071,000 408,023,000 408,672,000 365,961,000 361,766,000 364,206,000 362,942,000 361,795,000 355,292,000 355,528,000 360,968,000 359,345,000 355,240,000 353,842,000 242,586,000 243,347,000 238,100,000 235,426,000 233,211,000 239,724,000 212,171,000 215,157,000 214,517,000 214,489,000 216,046,000 195,974,000 201,022,000 199,873,000 199,521,000 196,670,000 180,601,000 178,228,000 180,952,000 180,657,000 181,941,000 178,934,000 180,392,000 179,705,000 176,932,000 184,450,000 176,537,000 181,619,000 180,466,000 180,521,000 180,988,000 171,403,000 172,459,000 174,994,000 174,614,000 150,018,000 154,191,000 152,498,000 149,112,000 148,597,000 143,252,000 146,534,000              
        intangible assets
      104,750,000 109,843,000 114,790,000 103,729,000 107,408,000 111,676,000 106,885,000 110,810,000 115,352,000 84,500,000 87,129,000 90,932,000 94,361,000 97,672,000 99,968,000 100,594,000 105,188,000 99,035,000 94,976,000 96,757,000 53,969,000 52,543,000 53,467,000 55,619,000 57,948,000 58,468,000 35,662,000 37,989,000 39,499,000 41,825,000 42,420,000 39,036,000 41,893,000 43,846,000 45,251,000 46,089,000 45,686,000 46,155,000 47,566,000 49,729,000 53,257,000 55,909,000 58,650,000 57,517,000 59,911,000 65,122,000 59,210,000 55,550,000 57,281,000 58,844,000 61,387,000 58,103,000 61,036,000 62,833,000 63,363,000 50,607,000 53,044,000 54,715,000 55,752,000 57,554,000 57,873,000 61,304,000              
        other long-term assets
      552,791,000 542,477,000 513,572,000 580,765,000 547,559,000 547,518,000 559,268,000 539,718,000 498,907,000 496,534,000 448,396,000 439,225,000 421,150,000 417,729,000 403,440,000 398,553,000 335,568,000 330,400,000 317,144,000 305,346,000 295,504,000 289,595,000 254,802,000 256,754,000 248,965,000 240,192,000 224,705,000 207,256,000 199,609,000 189,593,000 171,887,000 151,822,000 140,624,000 118,616,000 114,327,000 110,941,000 105,983,000 103,315,000 94,088,000 90,584,000 91,433,000 85,490,000 84,435,000 81,073,000 75,435,000 71,654,000 60,563,000 57,605,000 59,185,000 57,231,000 53,482,000 53,169,000 51,006,000 51,061,000 52,961,000 43,954,000 39,606,000 34,076,000 29,964,000 25,625,000 25,344,000 21,014,000 19,631,000 17,646,000 16,831,000 15,265,000 12,806,000 15,282,000 17,084,000 18,616,000 18,250,000     
        total long-term assets
      1,931,422,000 1,936,932,000 1,909,657,000 1,968,437,000 1,896,076,000 1,893,546,000 1,917,022,000 1,886,255,000 1,851,542,000 1,764,671,000 1,702,174,000 1,691,781,000 1,658,952,000 1,645,288,000 1,581,208,000 1,564,360,000 1,502,917,000 1,481,548,000 1,447,707,000 1,410,923,000 1,229,587,000 1,231,823,000 1,178,728,000 1,181,101,000 1,164,894,000 1,152,836,000 1,048,099,000 1,011,939,000 983,322,000 883,177,000 840,333,000 780,853,000 767,785,000 741,431,000 726,612,000 718,479,000 693,503,000 685,120,000 672,270,000 668,131,000 669,641,000 653,359,000 643,814,000 644,336,000 622,105,000 624,813,000 588,011,000 581,486,000 579,158,000 577,810,000 570,015,000 549,169,000 538,243,000 534,065,000 522,577,000 458,447,000 457,004,000 444,037,000 436,553,000 432,386,000 423,183,000 425,915,000 432,189,000 429,162,000            
        total assets
      3,385,497,000 3,350,759,000 3,386,712,000 3,330,794,000 3,213,689,000 3,293,443,000 3,350,766,000 3,414,867,000 3,353,515,000 3,259,925,000 3,086,404,000 2,870,806,000 2,808,398,000 2,746,765,000 2,640,067,000 2,607,185,000 2,592,689,000 2,437,203,000 2,385,744,000 2,412,149,000 2,327,385,000 2,294,561,000 2,047,407,000 1,960,713,000 1,886,245,000 1,832,475,000 1,751,481,000 1,724,237,000 1,680,968,000 1,537,349,000 1,544,530,000 1,520,685,000 1,469,492,000 1,713,416,000 1,669,334,000 1,637,137,000 1,572,091,000 1,530,704,000 1,500,370,000 1,489,241,000 1,478,647,000 1,474,993,000 1,477,210,000 1,477,370,000 1,431,014,000 1,384,211,000 1,290,632,000 1,283,193,000 1,262,324,000 1,230,516,000 1,195,238,000 1,164,071,000 1,132,638,000 1,103,602,000 1,093,351,000 969,199,000 950,575,000 909,478,000 897,144,000 862,297,000 833,735,000 824,284,000 808,527,000 814,889,000 798,510,000 770,504,000 765,437,000 778,693,000 764,889,000 736,857,000 702,179,000 674,233,000 646,169,000 646,494,000  
        liabilities and stockholders’ equity
                                                                                 
        current liabilities:
                                                                                 
        accounts payable
      129,974,000 110,408,000 122,265,000 116,585,000 120,096,000 114,211,000 110,603,000 117,468,000 117,462,000 110,643,000 112,609,000 107,664,000 117,709,000 110,221,000 110,144,000 127,262,000 120,881,000 116,140,000 86,684,000 93,016,000 87,175,000 74,558,000 71,933,000 73,903,000 74,210,000 72,172,000 75,515,000 67,606,000 70,143,000 69,534,000 65,457,000 68,015,000 70,409,000 66,968,000 60,583,000 58,606,000 62,249,000 60,057,000 44,127,000 50,085,000 52,458,000 52,648,000 53,614,000 58,212,000 44,183,000 44,743,000 58,255,000 41,425,000 42,794,000 29,941,000 38,131,000 37,584,000 38,716,000 35,288,000 31,728,000 31,032,000 29,888,000 23,334,000 22,669,000 25,273,000 23,190,000    26,472,000 23,541,000 28,006,000 28,937,000 25,357,000 25,301,000 32,510,000 21,786,000 28,366,000 27,316,000 19,160,000 
        accrued liabilities
      453,552,000 530,147,000 488,856,000 416,977,000 490,688,000 502,119,000 511,047,000 541,124,000 476,249,000 478,712,000 420,312,000 399,425,000 403,595,000 433,662,000 405,992,000 387,510,000 409,555,000 458,909,000 431,047,000 392,681,000 366,877,000 415,648,000 362,326,000 308,768,000 247,179,000 322,938,000 278,626,000 256,329,000 229,127,000 260,683,000 238,431,000 228,380,000 210,384,000 253,418,000 220,507,000 210,181,000 174,763,000 236,131,000 202,074,000 188,842,000 178,267,000 205,530,000 203,738,000 190,441,000 177,942,000 195,351,000 167,449,000 147,245,000 134,519,000 148,919,000 134,161,000 123,470,000 118,470,000 137,746,000 134,664,000 136,799,000 121,898,000 107,650,000 118,598,000 108,184,000 99,629,000 94,616,000              
        credit facility
      530,000,000 398,000,000 455,000,000 579,000,000 319,500,000 250,000,000 250,000,000 250,000,000 250,000,000 250,000,000 250,000,000 264,000,000 431,500,000 579,000,000                                                              
        current portion of long-term debt
      149,997,000 74,995,000 149,997,000 74,994,000 170,929,000 167,787,000 99,140,000 170,112,000 74,998,000 74,997,000 149,990,000 74,991,000 74,986,000 74,982,000    74,996,000 74,990,000 124,982,000 124,971,000 49,988,000 49,983,000                          1,050,000 1,035,000 1,019,000 1,137,000 1,122,000 1,107,000 960,000 903,000 890,000 877,000 863,000 850,000 838,000 825,000 813,000 801,000 788,000 777,000 765,000 754,000 742,000 731,000 720,000 710,000 699,000 1,313,000  
        current portion of deferred revenue
      36,328,000 35,264,000 35,693,000 36,324,000 35,000,000 33,799,000 38,434,000 37,998,000 38,193,000 37,195,000 37,282,000 37,779,000 37,839,000 37,938,000 40,809,000 40,775,000 40,905,000 40,034,000 41,128,000 41,130,000 41,639,000 42,567,000 42,599,000 36,317,000 38,028,000 41,462,000 42,986,000 43,446,000 43,351,000 41,290,000 41,149,000 40,921,000 40,545,000 29,181,000 29,203,000 28,706,000 28,065,000 27,380,000 26,007,000 25,849,000 25,943,000 25,583,000 24,914,000 28,775,000 31,820,000 31,812,000 29,560,000 27,682,000 23,810,000 21,458,000 22,441,000 21,980,000 21,269,000 20,192,000 16,494,000 13,635,000 12,913,000 14,119,000 13,983,000 10,714,000 13,681,000 12,234,000 12,610,000 10,994,000            
        total current liabilities
      1,299,851,000 1,148,814,000 1,251,811,000 1,223,880,000 1,136,213,000 1,067,916,000 1,009,224,000 1,116,702,000 956,902,000 951,547,000 970,193,000 883,859,000 1,065,629,000 1,235,803,000 1,189,945,000 1,166,547,000 971,341,000 763,579,000 633,849,000 651,809,000 620,662,000 582,761,000 526,841,000 540,584,000 846,241,000 725,337,000 626,627,000 618,909,000 689,619,000 770,444,000 759,537,000 774,316,000 728,838,000 1,004,567,000 996,543,000 1,001,493,000 936,077,000 934,568,000 760,208,000 822,776,000 878,668,000 856,761,000 824,766,000 775,428,000 803,445,000 820,906,000 630,264,000 600,352,000 517,173,000 478,353,000 592,952,000 551,671,000 439,577,000 406,333,000 415,846,000 336,369,000 298,137,000 272,570,000 285,112,000 270,933,000 271,200,000 289,167,000 256,305,000 198,563,000 213,110,000 292,143,000 295,292,000 307,750,000 299,052,000 265,026,000 223,392,000 209,170,000 213,569,000 188,415,000  
        long-term liabilities:
                                                                                 
        deferred income tax liabilities
      44,595,000 31,865,000 3,724,000 2,088,000 8,110,000 11,312,000 5,658,000 10,023,000 8,746,000 7,235,000 10,594,000 5,568,000 5,826,000 8,150,000 14,486,000 10,852,000 7,461,000 8,935,000 15,306,000 15,469,000 18,566,000 11,707,000 27,590,000 36,599,000 38,908,000 33,024,000 33,734,000 32,415,000 32,931,000 29,267,000 39,899,000 35,459,000 27,529,000 25,353,000 33,205,000 37,503,000 39,964,000 39,287,000 20,571,000 16,419,000 15,597,000 49,389,000 36,571,000 39,261,000 40,113,000 41,688,000 27,760,000 28,815,000 31,785,000 33,948,000 22,863,000 22,543,000 22,955,000 23,028,000 20,650,000 20,746,000 21,152,000 20,008,000 18,661,000 20,491,000 17,940,000 17,795,000 18,283,000             
        long-term debt
      299,854,000 374,842,000 374,825,000 449,812,000 449,799,000 449,786,000 524,758,000 524,743,000 620,778,000 622,883,000 618,813,000 696,844,000 696,362,000 694,387,000 760,814,000 767,995,000 773,381,000 775,205,000 778,025,000 780,079,000 778,747,000 858,492,000 853,316,000 899,562,000 697,363,000 698,910,000 696,634,000 700,552,000 699,334,000 601,348,000 602,416,000 603,130,000 609,005,000 606,075,000 604,149,000 600,891,000 594,868,000 593,110,000 599,137,000 597,958,000 600,021,000 597,085,000 599,556,000 598,925,000 500,000,000 350,000,000 350,000,000 150,000,000 150,090,000 150,359,000 624,000 884,000 1,141,000 1,394,000 1,776,000 2,735,000 2,966,000 3,194,000 3,418,000 3,639,000 3,856,000 4,070,000 4,281,000 4,489,000 4,694,000 4,896,000 5,094,000 5,157,000 5,350,000 5,540,000 5,727,000 5,911,000 6,092,000 6,271,000  
        long-term deferred revenue, net of current portion
      32,313,000 32,177,000   26,819,000 26,939,000 26,773,000 26,785,000 28,043,000 28,533,000 27,716,000 29,054,000 30,439,000 30,862,000 34,742,000 36,965,000 39,229,000 41,174,000 40,391,000 43,196,000 44,233,000 46,163,000 48,226,000 57,764,000 49,042,000 48,743,000 48,345,000 52,129,000 55,695,000 60,697,000 62,547,000 65,362,000 68,529,000 35,545,000 34,245,000 34,127,000 33,074,000 33,015,000 30,874,000 30,258,000 27,787,000 27,055,000 25,460,000 23,871,000 22,350,000 21,665,000 21,549,000 20,432,000 19,264,000 18,427,000 15,129,000 13,622,000 12,851,000 12,692,000 14,656,000 8,102,000 6,555,000 4,514,000 4,627,000 8,156,000 4,740,000 4,421,000 3,813,000 3,832,000            
        long-term operating lease liabilities, net of current portion
      98,747,000 101,151,000   97,004,000 97,836,000 103,420,000 102,965,000 103,879,000  101,470,000                                                                 
        other long-term liabilities
      54,034,000 56,527,000 57,621,000 56,788,000 47,731,000 44,341,000 62,879,000 53,396,000 66,261,000 65,526,000 60,211,000 64,283,000 70,864,000 67,587,000 70,953,000 69,777,000 71,848,000 70,941,000 72,993,000 85,043,000 83,549,000 85,604,000 79,664,000 84,207,000 81,293,000 81,164,000 77,078,000 79,352,000 82,564,000 84,826,000 81,494,000 83,267,000 84,573,000 95,718,000 49,583,000 49,230,000 42,020,000 38,937,000 34,594,000 30,328,000 30,361,000 28,698,000 29,660,000 31,334,000 31,027,000 32,363,000 31,588,000 30,664,000 31,760,000 31,215,000 28,775,000 25,760,000 24,819,000 23,898,000 22,888,000 15,279,000 12,954,000 12,284,000 11,045,000 12,426,000 11,722,000 11,699,000 11,266,000 12,272,000 12,429,000 11,476,000 11,137,000 11,527,000 13,939,000 13,984,000 13,830,000 17,363,000 18,261,000 18,069,000  
        total long-term liabilities
      529,543,000 596,562,000 573,715,000 648,087,000 629,463,000 630,214,000 723,488,000 717,912,000 827,707,000 823,848,000 818,804,000 893,086,000 901,668,000 902,225,000 974,123,000 983,630,000 981,550,000 983,632,000 996,435,000 1,012,117,000 1,003,288,000 1,079,005,000 1,079,451,000 1,146,729,000 931,949,000 929,313,000 922,132,000 933,779,000 939,479,000 776,138,000 786,356,000 787,218,000 789,636,000 762,691,000 721,182,000 721,751,000 709,926,000 704,349,000 685,176,000 674,963,000 673,766,000 702,227,000 691,247,000 693,391,000 593,490,000 445,716,000 430,897,000 229,911,000 232,899,000 233,949,000 67,391,000 62,809,000 61,766,000 61,012,000 59,970,000 46,862,000 43,627,000 40,000,000 37,751,000 44,712,000 38,258,000 37,985,000 37,643,000 116,692,000 114,826,000 32,533,000 31,951,000 33,616,000 37,376,000 38,195,000 40,464,000 44,923,000 48,048,000 45,995,000  
        total liabilities
      1,829,394,000 1,745,376,000 1,825,526,000 1,871,967,000 1,765,676,000 1,698,130,000 1,732,712,000 1,834,614,000 1,784,609,000 1,775,395,000 1,788,997,000 1,776,945,000 1,967,297,000 2,138,028,000 2,164,068,000 2,150,177,000 1,952,891,000 1,747,211,000 1,630,284,000 1,663,926,000 1,623,950,000 1,661,766,000 1,606,292,000 1,687,313,000 1,778,190,000 1,654,650,000 1,548,759,000 1,552,688,000 1,629,098,000 1,546,582,000 1,545,893,000 1,561,534,000 1,518,474,000 1,767,258,000 1,717,725,000 1,723,244,000 1,646,003,000 1,638,917,000 1,445,384,000 1,497,739,000 1,552,434,000 1,558,988,000 1,516,013,000 1,468,819,000 1,396,935,000 1,266,622,000 1,061,161,000 830,263,000 750,072,000 712,302,000 660,343,000 614,480,000 501,343,000 467,345,000 475,816,000 383,231,000 341,764,000 312,570,000 322,863,000 315,645,000 309,458,000 327,152,000 293,948,000 315,255,000            
        commitments, contingencies and guarantees
                                                                                 
        stockholders’ equity:
                                                                                 
        common stock
      10,850,000 10,837,000 10,830,000 10,804,000 10,792,000 10,784,000 10,770,000 10,769,000 10,767,000 10,751,000 10,745,000 10,738,000 10,732,000 10,719,000 10,709,000 10,707,000 10,700,000 10,688,000 10,681,000 10,675,000 10,668,000 10,646,000 10,628,000 10,603,000 10,591,000 10,571,000 10,559,000 10,548,000 10,535,000 10,509,000 10,504,000 10,485,000 10,468,000 10,428,000 10,412,000 10,395,000 10,374,000 10,334,000 10,312,000 10,283,000 10,255,000 10,258,000 10,213,000 10,235,000 10,226,000 10,195,000 10,170,000 10,163,000 10,155,000 10,119,000 10,081,000 10,068,000 10,061,000 10,016,000 9,991,000 9,910,000 9,884,000 9,856,000 9,797,000 9,762,000 9,729,000 9,679,000 9,633,000 9,616,000 9,583,000 9,563,000 9,539,000 9,531,000 9,502,000 9,487,000 9,450,000 4,716,000 4,700,000 4,688,000  
        additional paid-in capital
      1,861,079,000 1,826,750,000 1,792,787,000 1,727,410,000 1,695,613,000 1,673,863,000 1,646,363,000 1,625,451,000 1,604,749,000 1,569,565,000 1,543,024,000 1,515,197,000 1,489,903,000 1,463,215,000 1,437,528,000 1,419,709,000 1,400,025,000 1,377,320,000 1,358,813,000 1,339,413,000 1,321,086,000 1,294,849,000 1,274,069,000 1,247,456,000 1,230,485,000 1,213,517,000 1,189,554,000 1,170,962,000 1,155,875,000 1,138,216,000 1,128,484,000 1,109,157,000 1,094,159,000 1,073,931,000 1,060,689,000 1,046,473,000 1,030,147,000 1,011,895,000 994,299,000 972,360,000 952,943,000 940,534,000 931,808,000 921,678,000 912,582,000 888,293,000 866,213,000 856,350,000 847,138,000 825,320,000 798,332,000 787,191,000 779,261,000 757,214,000 742,022,000 694,201,000 680,093,000 665,035,000 641,645,000 626,521,000 613,416,000 593,924,000 580,797,000 573,590,000 561,454,000 553,446,000 548,661,000 544,077,000 532,950,000 526,169,000 514,773,000 512,266,000 500,447,000 493,404,000 383,249,000 
        deferred stock units: outstanding: 60 units in 2026 and 59 units in 2025
      6,169,000                                                                           
        retained earnings
      6,670,348,000 6,391,902,000 6,143,714,000 5,869,104,000 5,575,115,000 5,332,438,000 5,116,289,000 4,883,448,000 4,680,150,000 4,444,571,000 4,250,050,000 4,037,819,000 3,813,583,000 3,599,529,000 3,427,322,000 3,246,384,000 3,114,405,000 2,920,440,000 2,757,669,000 2,582,434,000 2,379,852,000 2,175,595,000 2,000,805,000 1,854,586,000 1,705,646,000 1,595,648,000 1,505,152,000 1,396,315,000 1,270,609,000 1,167,928,000 1,082,292,000 989,039,000 880,348,000 803,545,000 765,288,000 694,777,000 609,420,000 540,401,000 488,033,000 431,577,000 364,375,000 318,356,000 274,005,000 231,070,000 1,721,893,000 1,675,299,000 1,649,337,000 1,597,196,000 1,539,978,000 1,493,393,000 1,450,135,000 1,404,448,000 1,350,453,000 1,305,593,000 1,262,239,000 1,089,316,000 1,050,809,000 1,002,152,000 965,540,000 929,169,000 894,475,000 857,282,000 824,256,000 793,305,000 761,769,000 728,102,000 702,031,000 678,476,000 652,777,000 613,413,000 585,862,000 560,334,000 534,539,000 512,875,000 240,350,000 
        accumulated other comprehensive loss
      -64,940,000 -68,844,000 -72,950,000 -76,950,000 -90,091,000 -93,645,000 -75,971,000 -85,181,000 -80,397,000 -71,206,000 -74,891,000 -73,665,000 -76,615,000 -77,796,000 -80,894,000 -67,705,000 -47,348,000 -53,484,000 -52,057,000 -48,391,000 -59,536,000 -53,615,000 -61,925,000 -57,032,000 -55,246,000 -46,182,000 -45,565,000 -40,583,000 -40,015,000 -41,791,000 -42,187,000  -34,206,000 -36,470,000 -34,648,000 -38,388,000 -38,379,000 -43,053,000 -35,081,000 -35,465,000 -37,515,000 -42,265,000 -37,493,000 -22,275,000 -24,049,000                               
        treasury stock
      -6,927,403,000 -6,561,356,000 -6,319,424,000 -6,077,770,000 -5,749,272,000 -5,334,012,000 -5,085,282,000 -4,860,119,000 -4,651,873,000 -4,474,681,000 -4,437,044,000 -4,401,743,000 -4,401,666,000 -4,392,112,000 -4,323,842,000 -4,157,257,000 -3,843,749,000 -3,570,691,000 -3,326,021,000 -3,142,301,000 -2,953,923,000 -2,799,890,000 -2,788,412,000 -2,788,052,000 -2,788,310,000 -2,600,543,000 -2,461,698,000 -2,370,377,000 -2,350,034,000 -2,288,899,000 -2,185,152,000 -2,111,647,000 -2,005,813,000 -1,911,528,000 -1,856,307,000 -1,805,523,000 -1,691,204,000 -1,633,443,000 -1,408,183,000 -1,392,875,000 -1,369,412,000 -1,316,417,000 -1,222,812,000 -1,137,616,000 -2,591,714,000 -2,453,266,000 -2,303,575,000 -2,031,125,000 -1,904,604,000 -1,829,378,000 -1,744,319,000 -1,667,709,000 -1,525,023,000 -1,457,184,000 -1,415,940,000 -1,230,848,000 -1,163,102,000   -1,034,658,000   -914,759,000 -889,581,000 -871,206,000 -846,448,000 -830,390,000 -820,468,000 -800,325,000 -749,318,000 -696,668,000 -677,509,000 -670,359,000 -612,644,000  
        total stockholders’ equity
      1,556,103,000  1,561,186,000 1,458,827,000 1,448,013,000  1,618,054,000 1,580,253,000 1,568,906,000  1,297,407,000 1,093,861,000 841,101,000  475,999,000 457,008,000 639,798,000 689,992,000 755,460,000 748,223,000 703,435,000 632,795,000 441,115,000 273,400,000 108,055,000 177,825,000 202,722,000 171,549,000 51,870,000 -9,233,000    -53,842,000    -108,213,000 54,986,000   -83,995,000 -38,803,000 8,551,000 34,079,000 117,589,000 229,471,000 452,930,000 512,252,000 518,214,000 534,895,000 549,591,000 631,295,000 636,257,000 617,535,000 585,968,000 608,811,000 596,908,000 574,281,000 546,652,000 524,277,000 497,132,000 514,579,000 499,634,000 470,574,000 445,828,000 438,194,000 437,327,000 428,461,000 433,636,000 438,323,000 420,140,000 384,552,000 412,084,000  
        total liabilities and stockholders’ equity
      3,385,497,000 3,350,759,000 3,386,712,000 3,330,794,000 3,213,689,000 3,293,443,000 3,350,766,000 3,414,867,000 3,353,515,000 3,259,925,000 3,086,404,000 2,870,806,000 2,808,398,000 2,746,765,000 2,640,067,000 2,607,185,000 2,592,689,000 2,437,203,000 2,385,744,000 2,412,149,000 2,327,385,000 2,294,561,000 2,047,407,000 1,960,713,000 1,886,245,000 1,832,475,000 1,751,481,000 1,724,237,000 1,680,968,000 1,537,349,000    1,713,416,000    1,530,704,000 1,500,370,000   1,474,993,000 1,477,210,000 1,477,370,000 1,431,014,000 1,384,211,000 1,290,632,000 1,283,193,000 1,262,324,000 1,230,516,000 1,195,238,000 1,164,071,000 1,132,638,000 1,103,602,000 1,093,351,000 969,199,000 950,575,000 909,478,000 897,144,000 862,297,000 833,735,000 824,284,000  814,889,000 798,510,000 770,504,000 765,437,000 778,693,000 764,889,000 736,857,000 702,179,000 674,233,000 646,169,000 646,494,000  
        the accompanying notes are an integral part of these condensed consolidated financial statements.
                                                                                 
        commitments and contingencies
                                                                                 
        deferred stock units: outstanding: 59 units in 2025 and 60 units in 2024
       6,094,000   5,856,000                                                                       
        total idexx laboratories, inc. stockholders’ equity
       1,605,383,000    1,595,313,000    1,484,530,000    608,737,000    689,992,000 754,754,000 747,460,000 702,696,000 632,088,000 440,576,000 272,963,000 107,674,000 177,473,000 202,418,000 171,246,000 51,562,000     -54,106,000    -108,352,000 54,850,000   -84,125,000 -38,892,000 8,468,000 34,022,000 117,516,000 229,388,000 452,868,000 512,216,000 518,186,000 534,846,000 549,546,000 631,254,000 636,223,000 617,507,000 585,942,000 608,774,000 596,868,000  546,614,000 524,261,000 497,120,000              
        the accompanying notes are an integral part of these consolidated financial statements.
                                                                                 
        deferred revenue, net of current portion
        31,051,000 31,762,000                                                                        
        operating lease liabilities, net of current portion
        106,494,000 107,637,000                                                                        
        deferred stock units: outstanding: 60 units in 2025 and 60 units in 2024
        6,229,000 6,229,000                                                                        
        deferred stock units: outstanding: 60 units in 2024 and 59 units in 2023
           5,885,000 5,885,000 5,885,000                                                                    
        deferred stock units: outstanding: 59 units in 2024 and 59 units in 2023
              5,510,000                                                                   
        long-term operating lease liabilities
               99,671,000  97,337,000 98,177,000 101,239,000 93,128,000 98,041,000 89,631,000 87,377,000 89,720,000 88,330,000 78,193,000 77,039,000 70,655,000 68,597,000 65,343,000 67,472,000 66,341,000 69,331,000 68,955,000                                               
        deferred stock units: outstanding: 59 units in 2023 and 58 units in 2022
               5,530,000 5,523,000 5,515,000                                                                
        deferred stock units: outstanding: 58 units in 2023 and 58 units in 2022
                  5,164,000                                                               
        deferred stock units: outstanding: 58 units in 2022 and 90 units in 2021
                   5,182,000 5,176,000 5,170,000                                                            
        line of credit
                    633,000,000 611,000,000 400,000,000 73,500,000      121,596,000 486,824,000 288,765,000 229,500,000 251,528,000 346,998,000 398,937,000 414,500,000 437,000,000 407,500,000 655,000,000 686,250,000 704,000,000 671,000,000 611,000,000 488,000,000 558,000,000 622,000,000 573,000,000 542,500,000 498,000,000 549,500,000 549,000,000 375,000,000 384,000,000 315,000,000 277,000,000 397,200,000 367,500,000 260,000,000 212,000,000 232,000,000 154,000,000 132,548,000 126,590,000 128,999,000 125,912,000 133,862,000 157,388,000 118,790,000             
        deferred stock units: outstanding: 90 units in 2022 and 90 units in 2021
                      5,765,000                                                           
        deferred stock units: outstanding: 90 units in 2021 and 87 units in 2020
                       5,719,000 5,669,000 5,630,000                                                        
        noncontrolling interest
                        706,000 763,000 739,000 707,000 539,000 437,000 381,000 352,000 304,000 303,000 308,000 280,000 241,000 278,000 290,000 264,000 231,000 228,000 178,000 139,000 136,000 140,000 135,000 130,000 89,000 83,000 57,000 73,000 83,000 62,000 36,000 28,000 49,000 45,000 41,000 34,000 28,000 26,000 37,000 40,000 46,000 38,000 16,000 12,000 10,000             
        deferred stock units: outstanding: 87 units in 2021 and 87 units in 2020
                          4,549,000                                                       
        deferred stock units: outstanding: 87 units in 2020 and 143 units in 2019
                           4,503,000                                                      
        deferred stock units: outstanding: 147 units in 2020 and 143 units in 2019
                            5,411,000 5,402,000                                                    
        deferred stock units: outstanding: 144 units in 2020 and 143 units in 2019
                              4,508,000                                                   
        stockholders’ equity
                                                                                 
        deferred stock units: outstanding: 143 units in 2019 and 162 units in 2018
                               4,462,000 4,416,000                                                 
        liabilities and stockholders’ deficit
                                                                                 
        deferred stock units: outstanding: 144 units in 2019 and 162 units in 2018
                                 4,381,000                                                
        deferred stock units: outstanding: 162 units in 2019 and 2018
                                  4,592,000                                               
        marketable securities
                                       284,255,000 285,085,000 256,923,000 239,933,000 236,949,000 241,402,000 229,063,000 217,617,000 213,591,000 208,399,000 180,870,000 139,215,000                               
        deferred stock units: outstanding: 162 units in 2018 and 229 units in 2017
                                   4,524,000 4,455,000 4,398,000                                            
        total idexx laboratories, inc. stockholders’ deficit
                                   -9,513,000 -1,604,000 -41,127,000 -49,272,000  -48,622,000 -86,335,000 -74,090,000   -8,638,000 -73,922,000                                   
        stockholders’ deficit:
                                                                                 
        total stockholders’ deficit
                                    -1,363,000 -40,849,000 -48,982,000  -48,391,000 -86,107,000 -73,912,000   -8,498,000 -73,787,000                                   
        total liabilities and stockholders’ deficit
                                    1,544,530,000 1,520,685,000 1,469,492,000  1,669,334,000 1,637,137,000 1,572,091,000   1,489,241,000 1,478,647,000                                   
        accumulated other comprehensive income
                                     -42,559,000               1,990,000 15,031,000 14,445,000 13,622,000 15,562,000 10,493,000 11,687,000 15,954,000 14,579,000 18,709,000 26,468,000 19,587,000 13,467,000 11,429,000 2,924,000 6,543,000 10,341,000 8,440,000 4,766,000 -2,981,000 5,675,000 23,097,000 31,011,000 31,372,000 22,705,000 18,186,000 13,131,000 11,689,000 4,565,000 
        deferred stock units: outstanding: 217 units in 2018 and 229 units in 2017
                                      5,772,000                                           
        deferred stock units: outstanding: 229 units in 2017 and 231 units in 2016
                                       5,988,000 5,944,000 5,931,000                                        
        deferred stock units: outstanding: 225 units in 2017 and 231 units in 2016
                                          5,552,000                                       
        deferred income tax assets
                                               39,829,000 36,767,000 37,509,000 36,291,000 37,689,000 33,258,000 33,789,000 32,005,000 33,226,000 27,304,000 26,372,000 25,719,000 27,714,000 25,430,000 27,253,000 26,891,000 25,990,000 26,203,000 24,902,000 23,433,000 22,872,000 25,188,000 23,377,000 22,710,000 20,915,000 21,477,000 24,207,000 24,033,000 24,893,000 23,606,000     
        deferred stock units: outstanding: 231 units in 2016 and 240 units in 2015
                                           5,514,000                                      
        deferred stock units: outstanding: 231 and 240 units in 2016 and 2015, respectively
                                            5,470,000 5,482,000                                    
        deferred stock units: outstanding: 240 units in both 2016 and 2015
                                              5,432,000                                   
        deferred stock units: outstanding: 240 and 235 units in 2015 and 2014, respectively
                                               5,409,000 5,387,000 5,376,000                                
        deferred stock units: outstanding: 118 in 2015 and 2014
                                                  5,084,000                               
        deferred stock units: outstanding: 118 and 122 units in 2014 and 2013, respectively
                                                   5,066,000                              
        accumulated other comprehensive (loss) income
                                                   -8,071,000                              
        deferred stock units: outstanding: 123 and 122 units in 2014 and 2013, respectively
                                                    5,253,000 5,253,000                            
        deferred stock units: outstanding: 122 in 2014 and 2013
                                                      5,104,000                           
        deferred stock units: outstanding: 122 and 119 units in 2013 and 2012, respectively
                                                       5,110,000 5,055,000 5,055,000                        
        deferred stock units: outstanding: 119 units in 2013 and 2012
                                                          4,815,000                       
        deferred stock units: outstanding: 119 units in 2012 and 2011
                                                           4,630,000 4,616,000                     
        deferred stock units: outstanding: 119 and 118 units in 2011 and 2010, respectively
                                                             4,654,000 4,622,000                   
        deferred stock units: outstanding: 123 and 118 units in 2011 and 2010, respectively
                                                               4,742,000                  
        deferred stock units: outstanding: 118 and 117 units in 2010 and 2009, respectively
                                                                4,433,000                 
        total idexx laboratories’ stockholders’ equity
                                                                574,235,000    514,569,000             
        deferred stock units: outstanding: 117 units in 2010 and 2009
                                                                 4,391,000                
        deferred stock units: outstanding: 128 and 117 units in 2010 and 2009, respectively
                                                                  4,798,000               
        accounts payable, principally trade accounts
                                                                   24,104,000 19,133,000 21,465,000            
        deferred stock units: outstanding: 127 and 117 units in 2010 and 2009, respectively
                                                                   4,753,000              
        goodwill and other intangible assets
                                                                    212,612,000 214,974,000 207,682,000 200,748,000 207,095,000 231,379,000 242,137,000 244,781,000 236,414,000 235,881,000 230,562,000 227,369,000  
        accrued expenses
                                                                    33,094,000 38,031,000 33,548,000 29,482,000 32,857,000 31,660,000 34,749,000 32,481,000 29,182,000 37,360,000 33,049,000 32,595,000 23,926,000 
        accrued employee compensation and related expenses
                                                                    44,497,000 39,680,000 37,623,000 28,051,000 43,252,000 41,754,000 40,144,000 29,951,000 44,753,000 36,739,000 33,533,000 24,922,000 20,792,000 
        accrued taxes
                                                                    9,980,000 6,246,000 10,993,000 17,751,000 13,324,000 12,432,000 12,767,000 11,447,000 18,206,000 8,949,000 10,488,000 2,340,000 21,327,000 
        accrued customer programs
                                                                    17,388,000 18,749,000 18,054,000 16,193,000 15,183,000 17,813,000 16,306,000 14,421,000 15,107,000 16,302,000 15,195,000   
        deferred stock units: outstanding: 117 and 102 units in 2009 and 2008, respectively
                                                                    4,301,000             
        total liabilities and equity
                                                                    808,527,000             
        current portion of line of credit
                                                                     62,597,000 74,798,000           
        deferred tax liabilities
                                                                     16,099,000 13,819,000 12,339,000 11,933,000 11,265,000 12,228,000 12,600,000 14,697,000 14,656,000 15,286,000 14,871,000 236,000 
        line of credit, net of current portion
                                                                     80,000,000 80,000,000           
        deferred stock units: outstanding: 116 and 102 units in 2009 and 2008, respectively
                                                                     4,264,000            
        accounts receivables
                                                                      118,782,000 115,253,000 111,498,000 112,053,000 120,565,000 125,245,000 108,384,000 103,407,000 106,684,000 104,791,000  
        deferred revenue
                                                                      10,834,000 10,831,000 11,285,000 10,458,000 11,014,000 10,743,000 10,678,000 10,044,000 8,491,000 9,235,000 8,275,000 
        deferred stock units: outstanding: 115 and 102 units in 2009 and 2008, respectively
                                                                      4,208,000           
        short-term debt
                                                                       165,517,000 150,620,000 163,942,000 157,973,000 139,951,000 72,236,000 77,280,000 83,748,000 74,591,000  
        deferred stock units: outstanding: 113 and 102 units in 2009 and 2008, respectively
                                                                       4,146,000          
        deferred stock units: outstanding 102 and 82 units in 2008 and 2007, respectively
                                                                        2,678,000         
        deferred stock units: outstanding: 100 and 82 units in 2008 and 2007, respectively
                                                                         2,614,000        
        deferred stock units: outstanding: 99 and 82 units in 2008 and 2007, respectively
                                                                          2,546,000       
        deferred stock units: outstanding 99 and 82 units in 2008 and 2007, respectively
                                                                           2,513,000      
        short-term investments
                                                                                33,988,000 
        warranty reserves
                                                                                 
        deferred stock units: outstanding: 82 and 62 units in 2007 and 2006, respectively
                                                                            2,201,000     
        deferred income taxes
                                                                             24,303,000 22,852,000 21,125,000 13,775,000 
        property and equipment, at cost:
                                                                                 
        land and improvements
                                                                             7,734,000 7,624,000 7,460,000  
        buildings and improvements
                                                                             52,375,000 51,982,000 51,711,000  
        leasehold improvements
                                                                             15,788,000 14,667,000 13,437,000 23,139,000 
        machinery and equipment
                                                                             83,944,000 79,561,000 75,688,000 44,843,000 
        office furniture and equipment
                                                                             57,208,000 55,423,000 50,055,000 34,802,000 
        construction in progress
                                                                             16,170,000 9,275,000 6,803,000 2,824,000 
        less accumulated depreciation and amortization
                                                                             106,354,000 100,726,000 96,358,000 66,799,000 
        other long-term assets:
                                                                                 
        other noncurrent assets
                                                                             17,738,000 15,333,000 13,573,000 9,214,000 
        deferred stock units: issued 41 and 31 units in 2007 and 2006, respectively
                                                                             2,147,000    
        deferred stock units: issued 34 and 31 units in 2007 and 2006, respectively
                                                                              2,094,000 2,072,000  
        accrued marketing and customer programs
                                                                               16,103,000  
        long-term investments
                                                                                35,082,000 
        land
                                                                                1,202,000 
        buildings
                                                                                5,213,000 
        notes payable
                                                                                494,000 
        warranty reserve
                                                                                1,053,000 
        partner’s interest in consolidated subsidiary
                                                                                786,000 
        preferred stock, 1.00 par value; authorized: 500 shares, none issued and outstanding
                                                                                 
      Cashflow Statements:
      Quarterly
      Annual
        Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30 2009-06-30 2009-03-31 2008-12-31 2008-09-30 2008-06-30 2008-03-31 2007-12-31 2007-09-30 2007-06-30 2007-03-31 
                                                                                     
          cash flows from operating activities:
                                                                                     
          net income
        278,446,000 248,188,000 274,610,000 293,989,000 242,677,000 216,149,000 232,841,000 203,298,000 235,579,000 194,521,000 212,231,000 224,236,000 214,054,000 172,207,000 180,938,000 131,979,000 193,965,000 162,771,000 175,178,000 202,606,000 204,289,000 174,958,000 146,321,000 148,996,000 111,856,000 90,544,000 108,838,000 125,701,000 102,709,000 85,677,000 93,214,000 108,680,000 89,476,000 38,290,000 70,514,000 85,407,000 69,058,000 52,371,000 56,452,000 67,206,000 46,025,000 44,390,000 44,229,000 56,938,000 46,578,000 25,951,000 52,163,000 57,244,000 46,593,000 43,237,000 45,692,000 53,998,000 44,867,000 43,360,000 42,873,000 51,320,000 40,734,000 37,998,000 38,496,000 48,654,000 36,606,000 36,380,000 34,715,000 37,197,000 33,028,000 30,961,000 31,536,000 33,667,000 26,071,000 23,555,000 25,699,000 39,364,000 27,551,000 25,528,000 25,795,000 21,664,000 21,027,000 
          adjustments to reconcile net income to net cash from operating activities:
                                                                                     
          depreciation and amortization
        37,683,000 38,721,000 36,627,000 35,772,000 34,063,000 33,706,000 34,133,000 32,193,000 29,904,000 29,737,000 28,985,000 27,855,000 28,331,000 28,720,000 28,547,000 28,122,000 26,511,000 27,695,000 26,467,000 25,377,000 25,057,000 24,561,000 24,651,000 23,582,000 23,204,000 22,589,000 22,446,000 21,621,000 21,355,000 20,604,000 20,878,000 20,892,000 20,804,000 21,520,000 20,727,000 20,586,000 20,307,000 20,241,000 19,767,000 19,664,000 18,546,000 17,729,000 18,283,000 16,790,000 16,154,000 15,278,000 15,521,000 14,695,000 13,394,000 13,466,000 13,773,000 13,844,000 13,513,000 13,918,000 12,799,000 12,986,000 12,705,000 12,814,000 12,045,000 11,879,000 11,464,000 11,839,000 11,485,000 11,386,000 11,246,000 12,555,000 12,506,000 11,665,000 13,047,000 12,649,000 12,190,000 12,585,000 11,395,000 11,562,000 10,267,000 10,224,000 9,047,000 
          impairment charge
        5,000,000      250,000         1,353,000   508,000               1,118,000 1,110,000                                    
          provision for credit losses
        3,942,000  1,619,000 1,470,000 2,890,000  1,337,000 2,213,000 1,530,000  1,607,000 1,532,000 2,325,000  1,754,000 1,266,000 2,092,000  951,000 582,000 186,000  -117,000 1,123,000 4,229,000                                                     
          deferred income taxes
        13,890,000 31,529,000 93,248,000 2,479,000 3,948,000 4,676,000 -6,849,000 -19,450,000 -2,571,000 -33,557,000 -1,817,000 -9,175,000 -3,757,000 1,825,000 -13,373,000 -18,489,000 -5,028,000 -7,426,000 -144,000 -1,051,000 5,244,000                                                         
          share-based compensation expense
        16,340,000 16,111,000 14,433,000 14,854,000 14,615,000 14,258,000 15,918,000 15,719,000 14,400,000 15,223,000 15,224,000 15,362,000 13,930,000 13,279,000 12,948,000 12,370,000 11,173,000 9,713,000 9,530,000 9,637,000 8,875,000 7,943,000 7,927,000 7,797,000 7,284,000 16,655,000 9,391,000 6,898,000 6,334,000 6,209,000 6,596,000 6,392,000 5,960,000 5,755,000 6,020,000 6,087,000 5,655,000 4,870,000 5,094,000 5,005,000 4,922,000 5,124,000 5,118,000 4,990,000 4,652,000 4,636,000 4,643,000 4,712,000 4,108,000 4,274,000 4,157,000 4,159,000 3,949,000 4,268,000 4,012,000 3,863,000 3,809,000 3,999,000 3,996,000 3,536,000 3,965,000 3,475,000 3,185,000 3,258,000 3,344,000 2,774,000 2,908,000 3,011,000 2,930,000 2,418,000 2,485,000 2,720,000 2,878,000 2,202,000 2,461,000 1,697,000 2,416,000 
          other
        695,000 1,782,000 1,753,000 1,035,000 456,000 184,000 67,000 58,000 909,000 532,000 145,000 205,000 -362,000 613,000 832,000 965,000 235,000 217,000 1,102,000 967,000 333,000 891,000 -211,000 712,000 -13,000 -243,000 750,000 119,000 628,000 -1,485,000 772,000 522,000 1,091,000 453,000 310,000 -654,000 860,000 -174,000 -380,000 954,000 586,000 -167,000 -722,000   -81,000                                
          changes in assets and liabilities:
                                                                                     
          accounts receivable
        -56,808,000 13,864,000 -7,697,000 -29,649,000 -45,240,000 27,807,000 26,894,000 -29,140,000 -53,841,000 686,000 6,601,000 -17,025,000 -44,133,000 -6,337,000 18,733,000 -16,263,000 -37,531,000 15,909,000 1,671,000 4,014,000 -54,735,000 11,687,000 -15,132,000 -19,215,000 -38,062,000 1,979,000 13,248,000 -4,278,000 -33,421,000 14,640,000 -169,000 -11,072,000 -21,800,000 -6,194,000 13,676,000 -12,971,000 -19,429,000 -5,907,000 7,000,000 -2,143,000 -21,504,000 882,000 6,102,000 -5,688,000 -51,438,000 4,838,000 1,322,000 11,921,000 -21,707,000 -3,151,000 11,366,000 -439,000 -23,722,000 3,232,000 8,447,000 9,626,000 -17,818,000 -8,628,000 8,032,000       -23,000 5,969,000 -1,029,000 -6,072,000 -5,266,000 4,495,000 4,048,000 -13,543,000 -11,257,000 3,792,000 -1,642,000 -16,428,000 
          inventories
        2,239,000 1,413,000 1,879,000 -6,244,000 2,163,000 -3,245,000 -18,543,000 -3,801,000 -2,412,000 2,996,000 7,259,000 -15,019,000 -23,887,000 -22,110,000 -50,272,000 -30,495,000 -18,854,000 -6,028,000 -26,479,000 -12,493,000 -7,919,000 6,206,000 4,163,000 -14,820,000 -14,434,000 -724,000 -13,671,000 -8,390,000 -14,521,000 1,792,000 -10,590,000 -8,755,000 -8,070,000 3,904,000 -4,116,000 -13,481,000 -5,369,000 10,151,000 -2,717,000 -1,550,000 1,764,000 -7,731,000 -11,215,000 -5,881,000 -10,142,000 -25,672,000 -7,063,000 -7,775,000 2,200,000 5,013,000 -4,706,000 6,818,000 -8,472,000 4,326,000 -5,182,000 -4,209,000 -8,687,000 3,422,000 -4,040,000 -6,589,000 897,000     14,368,000 -1,269,000 1,191,000 -8,067,000 -4,331,000 -7,177,000 -6,483,000 -477,000 -2,508,000 -4,524,000 4,885,000 -3,083,000 
          other assets and liabilities
        -46,396,000 4,585,000 -21,038,000 -129,581,000 -10,325,000 -35,393,000 -64,055,000 40,199,000 -21,416,000 31,584,000 6,334,000 -18,929,000 -5,307,000 -15,283,000 7,163,000 -41,825,000 -52,904,000 -3,184,000 3,201,000 1,919,000 -57,081,000 29,659,000 26,039,000 69,421,000 -64,881,000 19,982,000 -8,948,000 3,779,000 -49,601,000 18,483,000 -2,433,000 -3,479,000 -52,302,000 58,152,000 10,692,000 17,105,000 -38,531,000 -529,000 16,374,000 19,790,000 -27,516,000                                     
          accounts payable
        11,217,000 -3,596,000 7,136,000 -3,990,000 -8,123,000 5,739,000 -1,455,000 8,252,000 -4,450,000 6,242,000 -2,644,000 -7,482,000 3,327,000 7,397,000 2,805,000 -2,719,000 -4,016,000 10,596,000 -3,175,000 1,352,000 2,460,000 469,000 7,241,000 -4,974,000 -1,755,000 776,000 5,211,000 -4,729,000 699,000 1,170,000 -1,339,000 1,942,000 -1,939,000 4,931,000 -4,962,000 5,109,000 -3,687,000 4,613,000 -2,595,000 1,900,000 -1,801,000 373,000 151,000 1,340,000 -4,332,000 -173,000 6,539,000 -1,520,000 1,857,000 -6,583,000 -365,000 -1,105,000 3,654,000 3,589,000 1,866,000 -10,749,000 3,990,000 5,579,000 1,303,000 6,454,000 548,000 -2,625,000 1,799,000 -773,000 5,081,000 -2,288,000 -5,184,000 2,631,000 -4,315,000 -695,000 3,815,000 92,000 -7,539,000 10,599,000 -6,717,000 1,034,000 935,000 
          net cash from operating activities
        266,248,000 355,760,000 402,340,000 185,743,000 237,962,000 262,025,000 220,079,000 248,312,000 198,585,000 249,851,000 272,433,000 200,314,000 183,912,000 173,428,000 189,000,000 65,850,000 114,706,000 209,964,000 187,205,000 233,955,000 124,422,000 218,934,000 193,116,000 208,142,000 27,871,000 155,413,000 132,265,000 137,102,000 34,378,000 135,648,000 110,708,000 118,830,000 34,898,000 121,126,000 110,684,000 110,192,000 31,274,000 100,115,000 100,315,000   73,896,000 76,946,000   27,303,000 93,263,000 81,762,000 33,518,000 66,267,000 79,727,000 79,318,000 20,684,000 76,794,000 74,688,000 63,616,000 15,184,000 57,182,000 75,208,000 63,092,000 25,218,000 48,850,000 54,898,000 55,880,000 19,205,000 59,449,000 44,622,000   33,494,000 41,674,000   39,931,000 32,057,000   
          capital expenditures
        -31,984,000 -29,434,000 -31,114,000 -34,102,000 -30,026,000 -29,255,000 -28,089,000 -33,305,000 -30,273,000 -32,556,000 -34,094,000 -27,470,000 -39,511,000 -49,229,000 -37,685,000 -30,086,000 -31,838,000 -31,788,000 -45,017,000 -22,581,000 -20,163,000 -14,190,000 -19,210,000 -24,556,000 -49,002,000 -45,911,000 -37,071,000 -33,781,000 -38,206,000 -33,109,000 -31,265,000 -27,651,000 -23,726,000 -20,014,000 -15,804,000 -14,919,000 -23,647,000 -14,831,000 -12,088,000   -15,404,000 -20,644,000   -18,019,000 -17,094,000 -14,112,000 -11,298,000 -17,005,000 -16,908,000 -23,938,000 -19,761,000 -22,262,000 -18,929,000 -14,855,000 -9,446,000 -12,537,000 -13,754,000 -13,803,000 -14,528,000   -24,255,000 -22,418,000   -15,488,000   
          free cash flows
        234,264,000 326,326,000 371,226,000 151,641,000 207,936,000 232,770,000 191,990,000 215,007,000 168,312,000 217,295,000 238,339,000 172,844,000 144,401,000 124,199,000 151,315,000 35,764,000 82,868,000 178,176,000 142,188,000 211,374,000 104,259,000 204,744,000 173,906,000 183,586,000 -21,131,000 109,502,000 95,194,000 103,321,000 -3,828,000 102,539,000 79,443,000 91,179,000 11,172,000 101,112,000 94,880,000 95,273,000 7,627,000 85,284,000 88,227,000   58,492,000 56,302,000   9,284,000 76,169,000 67,650,000 22,220,000 49,262,000 62,819,000 55,380,000 923,000 54,532,000 55,759,000 48,761,000 5,738,000 44,645,000 61,454,000 63,092,000 25,218,000 48,850,000 54,898,000 55,880,000 19,205,000 45,646,000 30,094,000   9,239,000 19,256,000   39,931,000 16,569,000   
          cash flows from investing activities:
                                                                                     
          purchases of property and equipment
        -31,984,000 -29,434,000 -31,114,000 -34,102,000 -30,026,000 -29,255,000 -28,089,000 -33,305,000 -30,273,000 -32,556,000 -34,094,000 -27,470,000 -39,511,000 -49,229,000 -37,685,000 -30,086,000 -31,838,000 -31,788,000 -45,017,000 -22,581,000 -20,163,000 -14,190,000 -19,210,000 -24,556,000 -49,002,000 -45,911,000 -37,071,000 -33,781,000 -38,206,000 -33,109,000 -31,265,000 -27,651,000 -23,726,000 -20,014,000 -15,804,000 -14,919,000 -23,647,000 -14,831,000 -12,088,000 -15,962,000 -21,906,000 -15,404,000 -20,644,000 -23,856,000 -23,017,000 -18,019,000 -17,094,000 -14,112,000 -11,298,000 -17,005,000 -16,908,000 -23,938,000 -19,761,000 -22,262,000 -18,929,000 -14,855,000 -9,446,000 -12,537,000 -13,754,000       -13,803,000 -14,528,000 -11,973,000 -9,114,000 -24,255,000 -22,418,000 -25,515,000 -17,049,000     
          acquisition of intangible assets
        -1,800,000              -10,000,000                                                            
          equity investments
        -799,000                                                                            
          proceeds from net investment hedges
        1,039,000 1,504,000 349,000 474,000 416,000 416,000 415,000 398,000 329,000 2,121,000                                                                    
          net cash used by investing activities
        -33,544,000 -28,130,000 -44,871,000 -33,628,000 -29,610,000 -39,843,000 -27,368,000 -32,907,000 -106,944,000 -30,435,000 -27,838,000 -27,470,000 -39,511,000 -49,229,000 -49,197,000 -55,086,000 -41,838,000 -44,040,000 -49,677,000 -174,663,000 -24,587,000  -19,460,000 -24,556,000 -49,670,000         -24,487,000 -41,487,000 -43,702,000 -29,012,000 -14,278,000 -22,946,000 -29,763,000 -23,799,000 -26,013,000 -54,806,000 -66,967,000 -160,620,000 -35,618,000 -23,449,000 -8,712,000 -12,634,000 -17,827,000 -27,374,000 -23,938,000 -16,920,000 -24,920,000 -18,929,000 -14,812,000 -7,344,000 -57,692,000 -16,349,000       -14,012,000 -20,702,000 -12,028,000 -6,879,000 -17,404,000 -22,684,000 -26,699,000 -24,808,000 -25,927,000   -56,041,000 
          cash flows from financing activities:
                                                                                     
          borrowings under credit facility
        132,000,000  -124,000,000 259,500,000 69,500,000                                                                         
          repurchases of common stock
        -351,036,000 -237,774,000 -240,195,000 -338,105,000 -400,890,000 -245,992,000 -220,757,000 -215,521,000 -154,764,000 -36,850,000    -74,020,000 -172,631,000 -306,765,000 -266,295,000 -244,756,000 -181,234,000 -188,525,000 -132,262,000 -182,815,000 -140,689,000 -85,975,000 -20,692,000 -54,302,000 -105,607,000 -73,828,000 -106,397,000 -83,487,000 -53,872,000 -57,895,000 -106,888,000 -63,910,000 -212,524,000 -15,026,000 -23,056,000 -53,480,000 -92,924,000 -88,960,000 -86,450,000 -133,647,000 -149,190,000 -272,342,000 -126,347,000 -70,279,000 -84,851,000 -76,575,000 -142,557,000 -63,778,000 -41,116,000 -36,146,000 -27,376,000 -27,630,000 -89,489,000 -67,597,000                   
          proceeds from exercises of stock options and employee stock purchase plans
        18,161,000 17,869,000 50,970,000 17,330,000 7,193,000 13,255,000 4,996,000 5,362,000 20,879,000 11,330,000 12,618,000 10,290,000 12,796,000 12,490,000 4,878,000 6,726,000 11,653,000 9,137,000 10,057,000 9,777,000 17,594,000 12,098,000 18,617,000 10,403,000 10,210,000 7,367,000 9,086,000 8,102,000 11,551,000 3,606,000 12,690,000 7,354,000 14,551,000 7,308,000 8,144,000 10,644,000 12,526,000 9,529,000 11,261,000 11,794,000 5,760,000 3,176,000 3,571,000 3,325,000 12,325,000 11,081,000 3,654,000 3,743,000 10,964,000 16,501,000 5,314,000 3,462,000 12,958,000 7,010,000 6,909,000 4,475,000 5,772,000 2,721,000 6,713,000 7,198,000 12,169,000 6,810,000 5,609,000 9,963,000 6,483,000 3,262,000 6,216,000 3,607,000 3,281,000         
          shares withheld for statutory tax withholding payments on restricted stock
        -10,555,000 -60,000 -85,000 -970,000 -6,124,000 -45,000 -218,000 -79,000 -10,189,000 -68,000 -231,000 -79,000 -9,597,000 -54,000 -162,000 -52,000 -10,338,000 -61,000                                                            
          net cash used by financing activities
        -211,430,000 -355,702,000 -313,310,000 -165,631,000 -330,321,000 -232,782,000 -290,979,000 -210,238,000 -144,074,000 -101,844,000 -43,038,000 -151,033,000 -146,081,000 -116,720,000 -148,829,000 -91,907,000 -13,480,000 -165,820,000 -221,726,000   398,000 -104,184,000   -74,389,000 -99,751,000 -109,488,000 -2,781,000 -117,806,000 -84,294,000   -78,058,000 -67,871,000   -76,612,000    -59,158,000    42,339,000 -76,268,000   -33,055,000 -40,331,000   -49,847,000 -37,231,000 -31,701,000 -6,564,000 4,010,000 -36,530,000       -44,755,000 -22,404,000   -20,680,000    -12,521,000    
          net effect of changes in exchange rates on cash
        -816,000 -24,000 -587,000 14,140,000 -2,327,000 -9,770,000 5,314,000 -1,010,000 -4,066,000 4,664,000 -2,699,000 -340,000 501,000 5,891,000 -6,160,000 -9,113,000 776,000 -853,000 -2,733,000 1,896,000 -2,949,000 4,699,000 822,000 1,843,000 -4,033,000 1,217,000 -2,037,000 700,000 -569,000 -1,081,000 119,000 -5,141,000 1,335,000 75,000 1,718,000 2,477,000 1,932,000 -4,396,000 811,000 201,000 3,330,000 -881,000 -4,479,000 1,325,000 -1,913,000 -4,223,000 -5,859,000 344,000 1,221,000 -1,138,000 1,776,000 -1,414,000 -1,638,000 518,000 1,100,000 -781,000 320,000 -1,104,000 -228,000 996,000 1,269,000 429,000    -682,000 1,468,000           
          net increase in cash and cash equivalents
        20,458,000    -124,296,000 -20,370,000 -92,954,000   122,236,000 198,858,000      60,164,000 -749,000 -86,931,000   208,341,000 70,294,000       -23,083,000 -27,682,000 15,330,000 -28,446,000 18,656,000 3,044,000 5,567,000 5,507,000 4,829,000 8,933,000 8,186,000 3,959,000 -12,156,000 -22,002,000 -19,008,000 -140,376,000 29,801,000 -12,313,000 18,845,000 7,145,000 14,247,000 13,798,000 22,649,000 4,378,000 2,545,000 19,628,000 16,322,000 1,596,000 2,396,000 22,101,000   23,403,000 15,537,000   2,984,000 17,449,000 7,427,000 -5,718,000 9,321,000       
          cash and cash equivalents at beginning of period
        180,070,000 288,266,000 453,932,000 112,546,000 144,454,000 383,928,000 90,326,000 123,794,000 187,675,000 154,901,000 128,994,000 322,536,000 279,058,000 223,986,000 183,895,000 156,915,000 106,728,000 78,868,000 60,360,000 61,666,000 
          cash and cash equivalents at end of period
        200,528,000 -28,096,000 43,572,000 624,000 163,970,000 -20,370,000 -92,954,000 4,157,000 397,433,000 122,236,000 198,858,000 21,471,000 111,367,000 13,370,000 -15,186,000 -90,256,000 204,618,000 -749,000 -86,931,000 -119,029,000 351,163,000 208,341,000 70,294,000 23,898,000 81,395,000 -13,670,000 -6,849,000 -5,771,000 116,616,000 -23,083,000 -27,682,000 15,330,000 159,229,000 18,656,000 3,044,000 5,567,000 160,408,000 4,829,000 8,933,000 8,186,000 132,953,000 -12,156,000 -22,002,000 -19,008,000 182,160,000 29,801,000 -12,313,000 18,845,000 286,203,000 14,247,000 13,798,000 22,649,000 228,364,000 2,545,000 19,628,000 16,322,000 185,491,000 2,396,000 22,101,000 5,939,000 153,459,000 23,403,000 15,537,000 11,621,000 106,354,000 2,984,000 17,449,000 86,295,000 -5,718,000 9,321,000 15,045,000 60,220,000 1,853,000 8,919,000 -4,349,000 53,937,000 
          supplemental cash flow information:
                                                                                     
          unpaid property and equipment, reflected in accounts payable and accrued liabilities
        8,274,000  -1,682,000 -2,242,000 10,702,000  2,083,000 -6,860,000 15,182,000  -4,120,000 2,995,000 12,453,000  9,321,000 -676,000 11,016,000  5,058,000 3,084,000 6,592,000  -4,962,000 -1,453,000 14,123,000  7,563,000                                                   
          the accompanying notes are an integral part of these condensed consolidated financial statements.
                                                                                     
          provision for uncollectible accounts
                                         485,000 571,000   328,000 590,000   392,000 360,000 939,000 509,000 357,000 890,000 337,000 451,000 375,000 446,000 136,000 644,000 271,000 642,000 -217,000 412,000 487,000 314,000 82,000 601,000 69,000 910,000 211,000 385,000 252,000 20,000 408,000 246,000 -529,000 885,000 301,000 523,000 238,000 81,000 179,000 116,000 
          deferred revenue
         713,000 -230,000 5,608,000 838,000 -3,643,000 -209,000 -1,229,000 703,000 315,000 -1,492,000 -1,246,000 -609,000 -7,600,000 -1,075,000 -1,407,000 -937,000 -64,000 -2,450,000 -2,750,000 -2,287,000 -2,940,000 -3,738,000 -4,285,000 -2,410,000 -1,534,000 -3,977,000 -3,751,000 -3,098,000 -1,405,000 -3,062,000 -1,925,000 -1,327,000 1,272,000 381,000 1,429,000 469,000 3,874,000 710,000 2,451,000 637,000 2,369,000 -1,982,000 -1,859,000 1,153,000 2,629,000 3,427,000 4,912,000 3,227,000 2,392,000 1,686,000 1,495,000 869,000 1,737,000 1,415,000 2,037,000 1,699,000 4,323,000 2,649,000   -200,000 12,000 2,034,000 524,000 1,623,000 -16,000 -477,000 -205,000 -278,000 -276,000 82,000 -333,000 -236,000 -110,000 716,000 167,000 
          acquisitions of intangible assets
                                -668,000         -2,000,000            -175,000   -659,000                         
          acquisitions of businesses, net of cash acquired
                                                    -383,000                                 
          borrowings (payments) on revolving credit facility
                                                                                     
          payments of senior notes
         -74,999,000                                                                          
          borrowings on term loan
                                                                                     
          payments of term loan
                                                                                     
          debt issuance costs
                             -30,000 -7,000   -12,000 -112,000 -30,000                                                 
          payments of acquisition-related contingent consideration and holdbacks
                  -99,000    -2,914,000                                                               
          the accompanying notes are an integral part of these consolidated financial statements.
                                                                                     
          acquisition of a business
                                                                                    
          net decrease in cash and cash equivalents
          43,572,000      -56,499,000    -1,179,000  -15,186,000      -32,765,000    -8,931,000  -6,849,000 -5,771,000 -7,178,000                                            -140,000  8,919,000 -4,349,000 -7,729,000 
          impairment charges
                                                                                    
          (payments) borrowings on credit facility
                                                                                     
          repayments under credit facility
                                                                                     
          acquisitions of a business
               -77,000,000                                                                     
          payments of acquisition-related holdbacks
                    -1,780,000                                                                 
          cash paid for income taxes
               77,685,000 13,233,000  63,733,000 89,927,000 7,200,000  51,395,000 116,925,000 11,400,000  14,180,000 69,752,000 12,171,000  49,926,000 17,963,000 12,020,000                                                     
          (repayments) borrowings on credit facility
                                                                                     
          purchase of minority interest
                                                                                     
          payment of acquisition-related contingent consideration and holdbacks
                                                                                     
          equity investment
                                                                                    
          acquisitions of a business, net of cash acquired
                          -4,660,000 -152,082,000 -4,424,000              -12,180,000 -2,349,000      -7,817,000    -6,355,000 -1,161,000                             
          (repayments) borrowings under credit facility
                  -14,000,000 -167,500,000 -147,500,000                                                                 
          payment of senior debt
                      -75,000,000                                                             
          proceeds from maturity of net investment hedges
                                                                                     
          borrowings (repayments) on credit facility
                                                                                     
          issuance of senior notes
                               100,000,000                                                 
          borrowings under revolving credit facility
                      22,000,000 211,000,000 326,500,000                                                             
          acquisitions of intangible assets and equity investments
                                                                                     
          borrowings (repayments) on revolving credit facilities
                                          -17,750,000                                           
          acquisition of intangible assets and equity investments
                                                                                     
          repayments on revolving credit facilities
                              -121,933,000    -22,013,000 -95,495,000 -52,024,000          -70,000,000                                       
          issuance of senior debt
                                                                                     
          payments of acquisition-related contingent considerations and holdbacks
                                                                                    
          acquisition of intangible assets and equity investment
                                                                                     
          shares withheld for statutory tax withholding on restricted stock
                           31,000 -14,983,000 -11,574,000 -361,000 -64,000 -8,604,000 -204,000 -277,000 -169,000 -7,403,000 -265,000 -390,000 -165,000 -8,555,000 -244,000 -370,000 -156,000 -7,303,000                                         
          borrowings on revolving credit facilities
                                            60,000,000    49,000,000    500,000  -9,000,000 69,000,000 38,000,000   107,500,000 48,000,000      21,417,000     -23,424,000 38,523,000   -11,237,000 15,019,000 -12,549,000 6,151,000 18,006,000 67,942,000     
          net cash (used) provided by financing activities
                            -129,651,000            -324,991,000                -14,960,000                             
          (benefit of) provision for deferred income taxes
                                                        -835,000     -109,000 -528,000                       
          purchases of marketable securities
                                                                                     
          proceeds from the sale and maturities of marketable securities
                                     284,125,000 61,943,000 68,913,000 68,427,000 87,476,000 51,582,000 44,162,000 37,929,000 70,186,000 32,064,000 14,672,000 6,811,000 3,228,000                                 
          net cash (used) provided by investing activities
                                 -95,911,000 -37,326,000 -34,085,000 -38,206,000                                                 
          repayment on revolving credit facilities
                                                                                     
          payment of acquisition-related contingent consideration
                             -96,000 -500,000   -120,000 -560,000 -1,122,000 -573,000 -266,000       -1,095,000 -916,000 -633,000 -2,084,000                                     
          acquisitions of a business and equity investment, net of cash acquired
                                                                                     
          benefit of deferred income taxes
                               -195,000 2,853,000  -1,023,000 132,000 3,294,000   5,633,000 3,005,000   750,000 1,941,000    2,520,000  -2,594,000    -1,504,000                          -999,000 -864,000 -3,864,000 -2,507,000 -1,839,000 
          borrowing (repayments) on revolving credit facilities
                                198,110,000                                                     
          net cash provided (used) by financing activities
                                16,901,000            1,313,000       -33,532,000 36,801,000        2,252,000                       -47,981,000 49,289,000 
          benefit of (provision for) deferred income taxes
                                     -11,641,000                                                
          acquisitions of intangible assets and equity investment
                                                                                     
          acquisitions of businesses
                                                                                     
          (repayment) borrowings on revolving credit facilities
                                                                                     
          purchase of marketable securities
                                      -87,000  -94,276,000 -85,030,000 -90,492,000 -49,065,000 -55,020,000 -51,730,000 -72,079,000 -40,571,000 -41,017,000 -49,922,000 -140,448,000                                 
          amortization on marketable securities
                                             116,000    465,000   91,000                                 
          tax benefit from share-based compensation arrangements
                                             -4,477,000 -5,434,000 -2,728,000 -2,063,000 -1,271,000 -1,298,000 -1,033,000 -7,713,000 -6,497,000 -1,621,000 -1,213,000 -6,747,000 -6,720,000 -1,608,000 -520,000 -5,310,000 -4,494,000 -4,236,000 -1,428,000 -4,518,000                     
          net cash provided (used) by investing activities
                                     -39,844,000 -54,215,000 -27,651,000 260,312,000                                             
          debt issue costs
                                             1,000 -57,000 -1,181,000 -72,000 -37,000 -90,000 -49,000 -201,000 -1,017,000 -139,000                             
          (repayments) borrowings on revolving credit facilities
                                      -22,500,000 29,500,000 -247,500,000          44,500,000                                   
          provision for deferred income taxes
                                                            1,169,000    462,000    2,501,000    769,000             
          (provision for) benefit of deferred income taxes
                                                                                     
          adjustments to reconcile net income to net cash provided (used) by operating activities:
                                                                                     
          proceeds from sale of equity investment
                                                                                   
          acquisition of businesses, net of cash acquired
                                                                                     
          payment of notes payable
                                                     -1,141,000 -253,000 -249,000 -378,000 -242,000 -238,000 -235,000 -230,000 -228,000 -224,000  -218,000                   
          provision for (benefit of) deferred income taxes
                                              4,727,000      565,000                     -435,000   1,465,000         
          issuance of long-term debt
                                                                                     
          net cash provided (used) by operating activities
                                                23,226,000                            12,624,000         
          net cash from financing activities
                                                1,202,000                            3,285,000    24,768,000     
          proceeds from disposition of pharmaceutical product lines
                                                         3,500,000 3,000,000 3,000,000     2,000,000 1,377,000         
          supplemental disclosures of cash flow information:
                                                                                     
          interest paid
                                                                        373,000 550,000 489,000 629,000 1,105,000 1,461,000 1,463,000 970,000 1,182,000 1,432,000 1,270,000 901,000 539,000 
          income taxes paid
                                                                        3,790,000 11,215,000 11,842,000 19,337,000 3,337,000 6,313,000 12,961,000 14,930,000 15,343,000 5,816,000 12,835,000 3,197,000 14,814,000 
          other assets
                                                  8,249,000 17,313,000 15,479,000 -21,698,000 -425,000 -4,262,000 1,312,000 -9,042,000 310,000 -1,894,000 6,301,000 3,394,000 3,375,000 329,000 -3,165,000 -4,395,000 -4,237,000 4,631,000 2,662,000    1,441,000 -4,716,000 -358,000 -2,947,000 179,000 -3,365,000 -295,000 84,000 -1,540,000 -7,181,000 103,000 -2,192,000 712,000 
          accrued liabilities
                                                  3,086,000 -1,364,000 -26,225,000 20,176,000 19,560,000 6,887,000 -10,231,000 19,781,000 8,418,000 5,232,000 -16,919,000 6,762,000 9,068,000 1,879,000 -14,698,000 900,000 21,835,000   14,157,000 9,015,000   5,946,000 -1,818,000 8,971,000 -12,394,000 2,067,000 3,924,000 17,670,000 -18,190,000 13,772,000 8,212,000 21,393,000 -11,453,000 
          issuance of long term debt
                                                    150,000,000                                 
          adjustments to reconcile net income to net cash (used) provided by operating activities:
                                                                                     
          gain on disposal of property and equipment
                                                    -33,000                                 
          increase in deferred compensation liability
                                                    58,000   93,000 -86,000 218,000 137,000 -25,000 114,000 8,000 88,000 -88,000 176,000 149,000 -391,000 -17,000 88,000 155,000    114,000            
          net cash (used) provided by operating activities
                                                    -14,644,000                                 
          acquisition of intangible asset
                                                                                     
          gain on disposition of pharmaceutical product lines
                                                                                     
          proceeds from sale of property and equipment
                                                             43,000 2,000 2,000 5,000 136,000 82,000 26,000 22,000 37,000 27,000 23,000 980,000 30,000 1,046,000         
          borrowings (payments) on revolving credit facilities
                                                         -120,200,000       11,000,000     3,008,000    -24,032,000         -8,796,000 5,316,000 74,511,000 
          supplemental disclosure of non-cash information:
                                                                                     
          market value of common shares received from employees in connection with share-based compensation – see note 17
                                                                                     
          receivable on disposition of pharmaceutical product lines
                                                                                     
          loss on disposal of property and equipment
                                                         -50,000 149,000 44,000 27,000 32,000 49,000 62,000 83,000 134,000 155,000 16,000 310,000 99,000 58,000 350,000 1,092,000 150,000 147,000           
          impairment of property and equipment
                                                                                     
          gain on sale of equity investment
                                                                                     
          (gain) loss on disposal of property and equipment
                                                        -18,000                             
          market value of common shares received from employees in connection with share-based compensation – see note 18
                                                                                     
          benefit from deferred income taxes
                                                                                     
          acquisition of a business, net of cash acquired
                                                                                     
          investment in notes receivable and related business
                                                                                     
          (payments) borrowings on revolving credit facilities
                                                             -20,000,000                        
          acquisitions of intangible asset
                                                              -900,000                     
          gain on disposition of pharmaceutical product lines and related restructuring
                                                                                     
          write-down of equine digital radiography intangible assets
                                                                                     
          write-down of marketable securities
                                                                                   
          changes in assets and liabilities, net of acquisitions:
                                                                                     
          payment of other notes payable
                                                                         -195,000 -295,000 -246,000 -190,000  -185,000 -180,000 -177,000 -185,000 -170,000 -719,000 -1,323,000 
          tax benefit from exercises of stock options and vesting of restricted stock units
                                                                  -3,155,000 -17,872,000 7,018,000 4,833,000 3,921,000 6,054,000 3,318,000 -1,343,000 -2,496,000 -1,194,000 -161,000         
          purchase of treasury stock
                                                                          -18,241,000 -24,739,000 -14,986,000  -20,098,000 -50,976,000 -51,355,000 -18,703,000 -7,151,000 -57,714,000 -34,819,000 
          loss on disposition of pharmaceutical product lines and related restructuring
                                                                                     
          purchases of treasury stock
                                                                                     
          increase (decrease) in deferred compensation liability
                                                                        101,000             
          acquisitions of equipment leased to customers
                                                                         -498,000 -474,000 -85,000 -188,000 -174,000 -131,000 -203,000 -226,000 -366,000 -215,000 -287,000 -238,000 
          navigator® inventory write-down and royalty license impairment
                                                                                   
          sales and maturities of short- and long-term investments
                                                                                 35,000,000 
          acquisitions of intangible assets and businesses, net of cash acquired
                                                                         -1,734,000    -135,000 -981,000 -7,533,000 -2,146,000 -2,231,000 -5,196,000 -80,311,000 
          market value of common shares received from employees in connection with share-based compensation – see note 16
                                                                                     
          consideration payable for acquisitions
                                                                                     
          note receivable on disposition of pharmaceutical product lines
                                                                                     
          increase in deferred compensation expense
                                                                                     
          decrease in deferred compensation expense
                                                                            -100,000         
          net effect of exchange rates on cash
                                                                            -1,603,000 -1,128,000 -3,927,000 -49,000 2,689,000 370,000 1,770,000 335,000 410,000 
          write-down of long-term assets
                                                                                     
          partner’s interest in loss of subsidiary
                                                                                     
          purchases of short- and long-term investments
                                                                                     
          purchase of land and buildings
                                                                                     
          payments of other notes payable
                                                                                     
          market value of common shares received from employees in connection with share-based compensation — see note 15
                                                                                     
          reduction (increase) in deferred compensation expense
                                                                                     
          tax benefit from exercises of stock options
                                                                              -2,708,000 -814,000 -2,384,000 -1,723,000 -3,474,000 -1,066,000 -3,004,000 
          sales and maturities of short-term investments
                                                                                     
          proceeds from exercises of stock options
                                                                              5,682,000 3,200,000 5,974,000     
          reduction in deferred compensation expense
                                                                               100,000 -131,000     
          adjustments to reconcile net income to net cash used by operating activities:
                                                                                     
          net cash used by operating activities
                                                                                -2,789,000    -1,387,000 
          noncash (gain) on investments
                                                                                     
          net proceeds from sale of land and buildings
                                                                                     
          market value of common shares received from employees in connection with share-based compensation – see note 15
                                                                                     
          receivable for purchase price adjustment of business acquisitions
                                                                                     
          noncash loss on investments
                                                                                     
          purchases of property, plant and equipment
                                                                                  -15,488,000 -15,743,000 -10,492,000 
          proceeds from exercises of options
                                                                                  5,669,000 4,070,000 7,916,000 
          excess tax benefit from exercises of stock options
                                                                                    3,004,000 
          changes in assets and liabilities, net of acquisitions and disposals
                                                                                     
          purchase of short- and long-term investments
                                                                                     
          purchase of property and equipment
                                                                                     
          acquisition of equipment leased to customers
                                                                                     
          acquisition(s) of business(es), net of cash acquired
                                                                                     
          proceeds from the exercise of stock options
                                                                                     
          cash and cash equivalents at beginning of year
                                                                                     
          cash and cash equivalents at end of year
                                                                                     
          supplemental disclosure of cash flow information:
                                                                                     
          value of mature shares exchanged in stock option exercises
                                                                                     
          payable for treasury stock